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GENERAL INTRODUCTION 
Mycoplasma dispar is a pathogen of the respiratory tract of calves that is 
known to cause chronic colonization of the tracheal mucosa. Although M. dispar 
rarely causes mortality by itself, it is known to predispose the animal to more 
severe infections with highly pathogenic bacteria such as Pasteurella hemolytica. 
This predisposing role is most likely related to the impairment of tracheobronchial 
clearance that has been demonstrated during infection with this mycoplasma 
(Thomas et al. , 1987; Howard and Thomas, 197 4) . 
With the aid of ruthenium red staining, Howard and Gourlay (1974) showed 
that M. dispar produces a polysaccharide capsule (capsular polysaccharide, CPS) 
during natural infections. The production of this CPS can also be induced in vitro, 
under conditions of co-culture with bovine lung fibroblasts (Almeida et al. , 1991 ). 
With CPS of other bacteria, it has been shown that the CPS can help the 
microorganism in evading phagocytosis. They can do so by conferring surface 
negative charges (Van Oss and Gilman, 1973) or by masking binding receptors on 
the microorganism for opsonic factors such as the C3b protein of the complement 
pathway (Horowitz, 1982). Capsules have also been shown to promote adherence 
of organisms to the surfaces of inanimate objects or living cells by formation of 
biofilms (Costerton et al. , 1987) and by binding irreversibly to negatively charged 
surfaces by a latch effect provided by the multiple binding sites from repeating 
units in the polysaccharides (Robb, 1984). Published work has shown the CPS of 
M. dispar to be involved in the suppression of several alveolar macrophage 
functions such as phagocytosis, tumor necrosis factor and interleukin-1 production 
(Almeida et al. , 1992). Participation of mycoplasma capsule in the attachment 
process has been suggested by Howard et al (1974) . The association of CPS with 
immunosuppressive activities and attachment of M. disparto host cells implicates 
the CPS as a virulence factor. 
Several attempts have been made to measure antibody responses to M. 
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dispar protein antigens (Howard and Gourlay, 1983; Howard, 1983. Scott et al. , 
1980; Thomas et al. , 1982) in naturally or experimentally infected cattle but almost 
none or very poor responses were seen. No work has been published on the 
immune responses to the capsular antigen in infected calves. There is no 
information available regarding the antigenic nature of purified CPS of M. dispar, 
i.e. whether it acts as a typical thymus independent type 2 antigen similar to other 
polysaccharides or whether it has some unique properties associated with it. 
There is preliminary evidence that the CPS of M. dispar is similar in 
chemical composition to polygalacturonic acid (pGalU) which is found in citrus 
rinds and other plant tissues (Almeida et al. , 1990). If vaccines based on the CPS 
provide protection against infection and tissue damage by M. dispar, then there is 
potential for use of inexpensive, commercially available pGalU instead of the CPS 
of M. dispar which is expensive to produce in large quantities. 
If the CPS of M. dispar does elicit thymus-independent responses, then in 
order to induce immunity in animals, thymus-dependent (TD) forms of the CPS will 
have to be constructed. Such TD forms will enable the host's immune system to 
elicit an anamnestic response, produce antibodies with much higher affinity for 
CPS and also produce lgG antibodies which can be transferred to the new-born 
through placenta and colostrum. One way to construct such forms of the CPS 
would be through chemical modifications and conjugation with a protein. 
However, such approaches to vaccine development require understanding of the 
chemical structure of CPS. 
The main objectives of this research project were 1) to characterize the 
immune responses towards pGalU and to the purified capsu le of M. dispar in mice, 
2) to characterize the immune responses to capsule and pGalU in calves infected 
with M. dispar, and 3) to chemically characterize the capsule of M. dispar. 
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Thesis organization 
This thesis is composed of a general review of the literature followed by two 
papers being submitted for publication to different journals. A summary of the 
entire thesis and one appendix are included. The references cited in the General 
Introduction , Literature Review and General Summary follow the General 
Summary. 
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LITERATURE REVIEW 
This literature review covers the area of bacterial capsular polysaccharides, 
including their structure and function. In concordance with the focus of the 
research , special emphasis has been laid on the immune responses towards 
polysaccharides. 
Bacterial extracellular polysaccharides 
Carbohydrates are universally present on the surface of living cells. On 
eukaryotic cells, many different carbohydrates are attached as glycoproteins and 
glycolipids; the oligosaccharide moieties are known to act as receptors and they 
are known to play an important role in cell to cell recognition processes. In 
prokaryotes, polysaccharide capsules characteristically composed of repeating 
oligosaccharides are found on the surface of many bacteria. 
Bacterial extracellular polysaccharides (EPS) are found in one of two forms. 
As a capsule (capsular polysaccharide, CPS), the polysaccharide is intimately 
associated with the cell surface and may be covalently bound but is distinct from 
and extraneous to the bilayer membrane. In contrast, slime polysaccharides are 
only loosely associated with the cell surface. Distinction between CPS and slime 
polysaccharides is operationally defined by the degree of cell association 
following centrifugation (Whitfield, 1988). Differentiation between the two forms 
may be difficult, since cells producing large amounts of CPS may release some 
material at the periphery, giving the appearance of slime production. Stable 
mutants that are no longer able to attach the polysaccharide in the form of 
capsules are found. It is not clear whether the mutants lose a transferase type of 
enzyme which is involved during the final stages of capsule formation or whether 
an attachment site on the cell surface is lost. Although no chemical differences 
have been reported between the capsule and slime polysaccharides prepared 
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from wild type strains and their slime-forming mutants, for Enterobacter aerogenes 
it was shown that the slime polysaccharides had a lower molecular weight than 
the capsular materia l (Wilkinson, 1958). Most bacteria show a preference of 
producing one form over another, although some strains of Klebsiella sp. and 
Staphylococci sp. (Wilkinson, 1983) can simultaneously produce identical 
capsule and slime. Several bacteria including strains of Rhizobium sp., 
Agrobacterium sp. and Alcaligenes facalis var. myxogenes are able to 
synthesize more than one chemically distinct exopolymer (Sutherland, 1985). 
Distinction between CPS and other cel l surface polysaccharides can also be 
difficu lt. The CPS K-antigens of some Escherichia coli K serotypes are now 
known to be lipopolysaccharides. 
Among the gram-positive cocci, streptococci and staphylococci have been 
reported to produce polysaccharide capsules. These include Streptococcus 
pyogenes, Streptococcus agalactiae, Streptococcus suis, Streptococcus 
pneumoniae, Streptococcus bovis, Streptococcus mutans, Streptococcus 
salivarious, Staphylococcus aureus and Staphylococcus epidermidis. Bacillus 
anthracis, a gram-positive rod also produces a capsule. Neisseria meningitidis 
and Neisseria gonorrhoeae (Hendley et al. , 1977) are the gram-negative 
coccobacilli that have been reported to possess capsules. Examples of 
encapsulated gram-negative rods are Escherichia coli, Salmonella typhi, 
Salmonella paratyphi C, Salmonella dub/in, members of Klebsiella species, 
Vibrio parahaemolyticus, Haemophilus influenzae, Pasteurella multocida, 
Pasteurella haemolytica and Bacteroides fragilis. 
The production of the EPS may be affected by growth conditions. Synthesis 
of alginate by mucoid strains of Pseudomonas aeruginosa is a growth -
associated process and the speci fic rate of its production in continuous culture 
increases with increased specific growth rate (Mian et al. , 1978). Alginate is 
produced mainly during the exponential phase of growth (Annison et al., 1987) 
although EPS synthesis commences with the onset of stationary phase. 
6 
Production of this EPS also depends on the temperature of growth , more alginate 
being produced per ce ll at 12 C than at 25 C and least at 37 C (Evans et al. , 1973). 
Also, addition of 5% glycerol and 0.25 M NaCl to MacConkeys agar stimulates 
EPS production at all temperatures. Capsule formation by Bacillus anthracis is 
optimal on special media under 5% C02 (Orskov et al. , 1990). Lee et al. , (1993) 
reported that there was an inverse relationship between capsule (type 8 CPS) 
expression by Staphylococcus aureus and the iron concentration in the culture 
media. A similar relationship has been reported in the case of Neisseria 
meningitidis (Masson et al. , 1985). Lee et al. , (1993) also reported that S. aureus 
produces 350 times more cell-associated CPS per miligram of biomass when 
grown on the surface of Columbia agar than when grown in Columbia broth. Most 
of the CPS produced by broth-grown cells was secreted in the culture medium. 
Mycoplasma extracellular polysaccharides 
Mollicutes lack a cell wall containing peptidoglycan and protein matrices as 
are found in most prokaryotes (Plackett, 1959). Similar to many bacteria, capsules 
have been described in several moll icute species. However, morphologically they 
appear to more closely resemble the glycocalyx of eukaryotes than the classical 
capsules of the more traditional eubacteria (Minion et al., 1993). 
Recently, two comprehensive reviews regarding the capsu lar 
polysaccharides of mycoplasmas have been published (Minion et al. , 1993; 
Rosenbusch et al. , 1992). Several mycoplasma species produce a measurable 
capsule including Mycoplasma mycoides sub sp. mycoides (Buttery et al. , 1960), 
Mycoplasma dispar (Howard et al. , 1974), Mycoplasma gallisepticum (Tajima et 
al. , 1979) , Mycoplasma hominis (Furness et al. , 1976) , Mycoplasma 
hyopneumoniae (Horn , 1970; Tajima and Yagashaki , 1982). Mycoplasma 
maleagridis (Green et al. , 1973) , Mycoplasma pneumoniae (Wilson et al. , 1976 ), 
Mycoplasma pulmonis (Taylor-Robinson et al. , 1981 ), Mycoplasma synoviae 
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(Ajufo et al. , 1978), Mycoplasma mobile (Rosengarten et al., 1988), and 
Spiroplasma citri (Cole et al. , 1973 ). Among the ureaplasmas, the human 
pathogen Ureaplasma urealyticum expresses capsule (Robertson et al. , 1976), 
but U. diversum has been described to have only a very thin exopolymer 
(Boatman et al. , 1976). Rurangirwa et al. (1987) have reported the production of 
an extracellular polysaccharide from Mycoplasma capricolum with a large 
molecular weight. Although no morphological data is available , it has been 
considered as the capsular polysaccharide (Minion et al. , 1993) in view of its 
molecular weight which has been shown to be greater than 200 Kd. Capsules 
have not been described among acholeplasmas, spiroplasmas, anaeroplasmas or 
asteroplasmas and therefore may be considered unique to mammalian 
pathogenic species. 
The traditional methodology used for studying bacterial capsules has not 
been applicable with great success to mollicutes because of their smaller size and 
the complex nature of background components provided by the media or animal 
tissue environment in which capsule is being expressed.The majority of the 
morphological information available has arisen from electron microscopy 
observations. Mostly, mycoplasma capsules have been visualized with the aid of 
polycationic compounds such as ruthenium red and polycationic ferritin which 
complex with osmium tetroxide to stain polyanionic compounds (Luft, 1964). 
Rosenbusch and Minion (1992) have rai sed the question whether capsular 
structures that are either not polyanionic or are not reactive with polycationic 
compounds exist among mycoplasmas but have not been reported. 
Lipoglycans (Smith, 1984) have been found in the members of these 
mollicute families , but these structures are considered integral to the mycoplasmal 
membrane (Minion et al. , 1993). These lipoglycans can be extracted by treatment 
of the whole cells or membranes alone with hot 45 % phenol (Smith, 1984). 
Therefore , capsular material that has been isolated by the use of hot phenol 
extraction procedures may be contaminated with lipoglycans. The use of milder 
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treatments such as prolonged exposure to buffered saline at 37° C for the 
extraction of capsule (Almeida et al. , 1992) would not be expected to remove the 
lipoglycans from the mycoplasmal membrane. Moreover, lipoglycans do not 
provide significant extracellular electron microscopic image when stained with 
ruthenium red and are of lower molecular weight than capsu les (Rosenbusch et 
al., 1992). 
Howard and Gourlay {1974), demonstrated capsule on the surface of M. 
dispar (grown in glucose - calf serum - broth) by ruthenium red staining. The M. 
dispar capsule extended about 17-24 nm and M. mycoides capsule about 30 nm 
beyond the cytoplasmic membrane. Similar to M. mycoides subsp. mycoides and 
M. meleagridis, the M. dispar capsule possessed no obvious structure. Thus the 
ultrastructure of the mycoplasma capsule is distinct from those of Diplococcus 
pneumoniae, where the capsule was found to have a fibrous structure and 
Klebsiella pneumoniae , where a spike or net-like appearance was observed 
(Springer and Roth , 1973). With the aid of ruthenium red staining, mycoplasma 
capsules could be seen as amorphous layers. Capsules of up to 40 nm in 
thickness were seen surrounding M. hyopneumoniae in infected porcine lung 
tissue (Tajima et al. , 1982). 
Little is known concerning the effects of environmental factors on capsule 
production. In some species, capsule seems to be produced constitutively 
whereas others synthesize the capsular polysaccharide to a considerable extent 
only during in vivo growth. M. dispar produces little capsule in vitro but produces 
significant amounts in vivo or when cocultured with bovine lung fibroblasts 
(Almeida et al. , 1991 ). Increases in the thickness of the capsule have been shown 
to occur with cocultured M. gallisepticum (Tajima et al. , 1979) and M. 
hyopneumoniae (Tajima et al. , 1982). The nature of the interaction occurring 
between eucaryotic cells and the mycoplasmas is still undefined, but in the M. 
dispar model it has been shown that a dialysis membrane with a 14,000 
molecular weight cut-off can be interposed between cells and mycoplasmas 
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without interfering with the induction of capsule synthesis (Almeida et al. , 1991 ). 
Structures of bacterial and mycoplasma polysaccharides 
Methods for structural elucidation of polysaccharides 
The immunogenicity and the immunological specificity of polysaccharide 
antigens is dictated by their structures. Hence, in order to understand the 
immunology of polysaccharides and to develop effective prophylactic vaccines 
against encapsulated bacteria, it is imperative that the structure of the 
polysaccharide capsu le be elucidated. 
Many chemical techniques have been utilized to determine the structures of 
the bacterial and mycoplasma capsules. 
Thin-layer chromatography is generally used in conjunction with acid 
hydrolysis and enzymatic cleavage to determine the monosaccharide 
composition . Rurangirwa et al (1987) determined the composition of the 
polysaccharide obtained from F-38 strain of mycoplasma (etiologic agent of 
contagious caprine pleuropneumonia) by thin layer chromatography of the 
trifluoroacetic acid hydrolyzed polysaccharide. The acid hydrolyzed 
polysaccharide consisted of glucose, galactose, mannose, fucose , glucosamine 
and galactosamine in approximately equal quantities. 
Methylation analysis of polysaccharides has been used to provide 
information regarding the amount and the point of branching in the 
polysaccharide. The free hydroxyl groups in the polysaccharide are methylated by 
reaction with methylsulfinyl carbanion and methyl iodide. The methylated 
polysaccharide is then hydrolysed, and the resu lting partial ly methylated 
monosaccharides are reduced, acetylated and analyzed by gas chromatography 
coupled to mass spectrometry. Rodriguez et al (1988) methylated the carboxyl-
reduced capsular K4 antigen of E. coli 05 :K4:H4 and found that there were 3 
partially methylated polyol acetates in the mixture : 2,5-di-O-acetyl-1 ,3,4,6-tetra-O-
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methylmannitol ; 1,4,5-tri-O-acetyl-2 ,3,6-tri-0-methylglucitol and 1,3,4,5-tetra-O-
acetyl-2 ,6-di-O-methylglucitol. From these results , the authors inferred the 
presence of 3,4-linked glucuronic acid , 3-linked N-acetylgalactosamine and 
terminal fructofuranose in the K4 polysaccharide. 
Another technique that has been used with great success in determining 
the structures of polysaccharides is nuclear magnetic resonance spectroscopy . 
This technique has many advantages over other chemical degradation 
techniques. NMR spectroscopy is not destructive of the sample whereas all the 
other techniques are. Besides, other techniques can only provide partial 
information regarding the structure of the capsule whereas structures of many of 
the bacterial polysaccharides have been deduced almost entirely by NMR 
spectroscopy (Bhattacharjee et al., 1975; Crise! et al. , 1975). The first NMR 
spectroscopic technique to be exploited was 13C NMR which yielded valuable 
information on the structure and conformation of polysaccharides (Jennings et al. , 
1977; Egan, W., 1980; Bundle et al., 1974). A spectra obtained on 13C NMR 
spectroscopy of bacterial polysaccharides contains signals associated with all the 
individual carbon atoms of their basic skeleton. Despite the large number of 
carbons in these molecules, the pattern of these signals is simplified by the 
coincidence of the carbon signals of their individual identical repeating units. 
Bhattacharjee et al (1975) performed 13C NMR on the group B meningococcal 
polysaccharide. Despite the large molecular size of the polysaccharide, the NMR 
spectrum was found to be a eleven-resonance spectrum, containing one signal for 
each carbon in its o:-(2-->8)-linked sialic acid repeating unit. Thus the simple 
pattern of the signals provided good evidence for the group B meningococcal 
polysaccharide to be composed of the above repeating unit. In addition, further 
structural information was obtained by comparing the chemical shifts of the carbon 
atoms of methyl a- and ~- ketosides of sialic acid with those of the sialic acid 
residues in the polysaccharide. Large chemical shift differences at C-8 and 
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smaller ones at C-7 and C-9 confirmed that the sialic acid residues were linked at 
0-8, and similarities in the chemical shifts of C-1 , C-4 and C-6 of the methyl a-
ketoside with those of the sialic acid residues in the polysaccharide enabled the a-
configuration to be assigned to these residues. Also , chemical shifts have also 
been demonstrated to be conformationally sensitive ( Bundle et al. , 197 4). Thus , 
overall 13C NMR spectroscopy has proved to be a powerful technique in the 
structural determination of bacterial polysaccharides. 
As in the case of 13C-NMR spectra, the 1 H-NMR spectra of polysaccharides 
are considerably simplified due the presence of a single repeating unit. However 
due to the presence of a large number of protons, the one-dimensional 1 H-NMR 
spectra are generally more poorly resolved as compared to 13C-NMR spectra. The 
chemical shifts of the proton signals can be used to make proton assignments , 
and changes in chemical shifts following specific chemical modifications of 
polysaccharides can be used to provide valuable conformational information. The 
added advantage of 1 H-NMR spectroscopy is due to the phenomenon of proton-
proton coupling , from which the relative orientation of vicinal protons can be 
established. However, because of the complexity of most one-dimensional 1 H-
NMR spectra, this technique is usually used for assigning anomeric proton signals 
which resonate in the characteristic low field part of the spectrum. 
The ability to make assignments to the peaks has been greatly facilitated 
with the advent of two-dimensional techniques. These techniques have been used 
for the structural elucidation of the groups I (Michon et al., 1985a) and K (Michon et 
al. , 1985b) meningococcal polysaccharides. By performing proton homonuclear 
shift-correlated 2-D NMR (1 H-1 H COSY) and heteronuclear shift-correlated 2-D 
NMR (1 3C-13C COSY) experiments, the investigators were able to make 
unambiguous assignments to all the protons and carbons of the repeating units. 
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Structures of capsu lar polysaccharides 
The capsular polysaccharides produced by microorganisms are cell-
surface polymers consisting of repeating oligosaccharide units. They may be 
linear homopolymers of a single carbohydrate moiety, e.g. meningococcal groups 
A,B and C polysaccharides ; linear heteropolymers composed of two or more 
monosaccharides, such as pneumococcal types 3 and 19F polysaccharides; or 
they may be multi-chained polymers composed of two or more monosaccharides 
and additional moieties, e.g. 0 -acetyl, pyruvic acid , glycerol, ribitol and 
phosphodiester bonds such as pneumococcal types 1, 4, 18C, 6 and 19A 
polysaccharides. 
Based on the type of the capsular polysaccharide present, N. meningitidis 
has been classified serologically into groups A, B, C, 29e, W135, X, Y and Z. 
Group A PS is a homopolymer of 2-acetamido -2-deoxy 0 -mannopyranosyl 
phosphate (Bundle et al, 1974) and group Xis a homopolymer of 2-acetamido -2-
deoxy 0 glucopyranosyl phosphate (Bhattacharjee et al. , 1975). Group Band C 
PSs are homopolymers of sialic acid. The groups Y and W135 contain 0-glycosyl 
and 0-galactosyl residues respectively in addition to sialic acid. The group Z 
contains glycerol-3-phosphate in addition to 2-acetamido -2-deoxy -0-
galactopyranose residues . 
According to their type specific capsular polysaccharides,H. influenzae can 
be classified serologically into six types (a through f). Types a, b, c and f contain 
phosphodiester linkages. Types d and e contain N-acetyl mannuronic acid. All of 
H. influenzae polysaccharides are high molecular weight negatively charged 
surface polymers. Except for type e, all types have a relatively simple structure , 
being a 0 -ribofuranosyl -0- ribitol phosphate polymer (Crisel et al. , 1975). 
Capsular antigens of E. coli are acidic polysaccharides with different 
chemical compositions which have been grouped into two kinds depending upon 
the molecular weight and the acidic components present. The type I capsular 
polysaccharides have molecular weights greater than 100 Kd and the acidic 
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components are glucuronic acid , galacturonic acid and pyruvate whereas the type 
II polysaccharides are less than 50 Kd and contain glucuronic acid , N-
acetylneuraminic acid, phosphate and 2-Keto-3-deoxymanno-octonic acid (KOO) 
as their acidic components. The structures of the capsular K polysaccharides have 
been reviewed by Jann and Jann (1990). 
The structures of the capsular antigenic polysaccharide from most of the 
eighty types of the gram-negative bacterium Klebsiella have been elucidated and 
a complete account of them has been reported (Isaac, 1985). Klebsiella K5 
capsular polysaccharide is a linear trisaccharide repeat including two charged 
groups , namely a glucuronic acid residue and a 4,6-ketal pyruvate attached to the 
mannose residue. An 0-acetate is attached at the 2-position of the glucopyranose 
ring . Klebsiella KB is a tetrasaccharide sequence consisting of three neutral sugar 
residues in the backbone and a charged glucuronic acid residue in the side chain . 
Klebsiella K9 is a pentasaccharide repeat consisting of four neutral sugar 
residues (three L-rhamnose residues and one D-galactose residue) in the 
backbone and one charged glucuronic acid residue as the side appendage. The 
chemical repeating sequence of the Klebsiella serotype K18 is the most complex 
of Klebsiella polysaccharides. It is a polyhexasaccharide consisting of a 
trisaccharide backbone repeat with a trisaccharide side chain attached to the c:x.-D-
glucose residue of the backbone. The only charged group in the repeat is the 
carboxyl of the ~-D-glucuronic acid moiety which is the middle residue of the side 
chain . Another interesting polysaccharide is that of serotype K25 which consists of 
a tetrasaccharide repeat with a polydisaccharide backbone and a disaccharide 
chain attached. The backbone is similar to the animal connective tissue 
polydisaccharide, hyaluronic acid, the chondroitin sulfates and dermatan 
sulfate.The charged group in the repeat is the carboxyl of the glucuronic acid 
residue which is attached directly to the backbone. 
AmongS. pneumoniae strains, 83 type specific polysaccharides are 
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produced which have been designated 1-83 in the U.S. system. The Danish 
system has combined closely related types into groups. Most pneumococcal 
polysaccharides are negatively charged and possess acidic components, 
including D-glucuronic acid (e.g. types 2, 3, 5, 8, 9A, and 9V) , D-galacturonic acid 
(e.g. type 1) and phosphate in phosphodiester bonds (e.g. types 6A, 68, 1 OA, 11 A, 
158, 19F, 19A, 20 and 23F). Type 4 polysaccharide contains pyruvate as its acidic 
component, while type 12F contains 2-acetamido-2-deoxy-D-mannuronic acid as 
the acidic component. The structures of pneumococcal polysaccharides have 
been reviewed (Jennings 1990). One property of the pneumococcal 
polysaccharides that enabled limitation of their number in the vaccine was their 
extensive serologic cross-reactivity demonstrated in animal experiments. The 
origin of this cross-reactivity is the extensive structural homology found in the 
pneumococcal polysaccharides, which is exemplified in the Danish serotyping 
system. 
Group B streptococci produce four type-specific polysaccharides: la, lb, II , Ill 
and IV. The structures of all but the last have been elucidated (Jennings et al. , 
1983a; Jennings et al. , 1983b; Wessels et al. , 1987). All the polysaccharides 
contain D-galactose, D-glucose, 2-acetamido-2-deoxy-D-glucose and sialic acid. 
This 3-0-(N-acetyl-a-neuraminyl) - ~-D-galactopyranosyl group of these 
polysaccharides is the end-group oligosaccharide in the human M and N blood 
group substances and thus the organism can effectively evade the human immune 
system (Jennings , 1990). 
The structure of the capsular polysaccharide of M. mycoides subsp. 
mycoides and Mycoplasma sp. bovine arthritis strain have been elucidated. The 
polysaccharide is a galactan of unusual structure consisting of galacto-furanosyl 
units in 1->6 ~ linkage (Plackett and Buttery, 1964). The predominant structural 
unit of the glucan from the bovine arthritis strain is ~- D-glucopyranosyl-(1->2)-D ­
glucopyranose (Plackett et al. , 1963). 
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Function of the capsules 
Capsules are important determinants of the behaviour of bacteria within the 
animal host. Comprising 99 % of water, these highly hydrated polysaccharide 
capsules may serve many functions most of which are protective in nature. 
Capsules may enhance survival and faci litate spread of bacteria from one host to 
another by preventing dessication. They may significantly affect the access of 
molecules and ions to the bacterial cell envelope and the cytoplasmic membrane 
(Dudman, 1977). Cells buried within a polymer matrix, may, for instance , be 
inaccessible to antibacterial agents such as antibiotics (Costerton et al. , 1987). 
Capsules may promote adherence of bacteria to the surfaces of inanimate 
objects or living cells by formation of biofilms (Costerton et al. , 1987) and by 
binding irreversibly to negatively charged surfaces by a latch effect provided by 
the multiple binding sites from repeating units in the polysaccharides (Robb, 
1984). Association between attachment and virulence of mycoplasma species was 
reported by several authors (Gabridge, 1983; Bredt et al. , 1981) and participation 
of the mycoplasma capsule in the attachment process was suggested (Green and 
Hanson, 1973; Wilson and Collier, 1976; Howard et al. , 197 4) . Electron 
microscopy pictures of M. dispar attached to RSC have shown the presence of 
ruthenium red stainable capsular material and fine threads of extracellular 
material bridging gaps between membranes. The author suggested that this was 
evidence of participation of M. dispar capsule in the attachment process (Howard 
et al. , 197 4). Similar observations and suggestions were made by Tajima and 
Yagihashi (1982) in their study of the interaction of Mycoplasma hyopneumoniae 
with porcine respiratory epithelium using transmission electron microscopy. 
Among certain gram-positive and gram-negative bacteria, capsules have 
evolved distinctive structural and functional characteristics which are of cardinal 
importance in the pathogenesis of infection of animals, plants and insects. 
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Capsulated bacteria are responsible for causing some of the most serious 
invasive infections to which man is susceptible , including septicemia, meningitis , 
pneumonia, osteomyelitis, septic arthritis and pyelonephritis. The morbidity and 
mortality caused by these infections is substantial and their capsules have been 
implicated as the major virulence factors (Robbins, 1978). The type of EPS , the 
amount synthesized and the rate of synthesis may all have a bearing on the 
pathogenicity of an organism. 
Capsules seem to be particularly important in bacteria whose strategy for 
survival in the host depends on the evasion of phagocytosis (Dudman, 1977; 
Horowitz and Silverstein , 1980; Jann and Jann , 1983). Most capsular 
polysaccharides are hydrophilic and confer a negative charge on the bacterial 
cell , characteristics which are intrinsically antiphagocytic in their effect. The 
experimental observations of Ponder (1928) , Van Oss and Gillman (1973) , and 
Absolom (1988) were the basis of the assumption that the hydrophilic properties of 
polysaccharide capsules act by reducing the surface tension at the interface 
between the phagocytic cell and the bacterium. This impaired the abi lity with 
which phagocytic ingestion occurs. In biological fluids containing lgG , most non-
encapsulated microorganisms, because of their hydrophobic surface (increased 
aqueous surface tension) non-specifically adsorb lgG. It was found that an lgG 
coat and the subsequent complement activation with deposition of C1423 enhances 
the surface hydrophobicity which increased the phagocytic engulfment of 
microorganisms by the PMNs. Encapsulated microorganisms, which were 
hydrophilic did not absorb lgG at their periphery to any significant extent and failed 
to induce efficient phagocytic ingestion. Because of the surface charge, the contact 
between the capsulated bacteria and the phagocytic cell is compromised since the 
negative charge on each cell results in mutual repulsion . Thus, due to the physical 
properties of CPS including hydrophilicity and charge , the phagocytic ingestion of 
capsulated organisms is inefficient in the absence of factors which facilitate 
contact between the bacterium and the phagocytic cell and which modify the 
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hydrophilic bacterial surface. 
Microorganisms have been found in host systems forming microcolonies 
immersed in a glycocalyx which creates a protective niche where individual 
microorganisms survive host defense mechanisms. Isenberg (1988) reported that 
the microorganisms were immersed in a protective halo made up of joined 
individual exopolysaccharides which were resistant to degradation by mammalian 
enzymes. Consequently, phagocytes were unable to break the exopolysaccharide 
barrier to engulf these microcolonies. 
Many host factors can act as opsonins which modify the surface of 
capsulated bacteria, but C3b - the cleavage product of the third complement 
component- is of central importance, especially against invasive infections caused 
by capsulate bacteria (Winkelstein , 1981 ). C3b can be generated by two 
independent mechanisms, the alternative and classical pathways. The formation 
of C3b through the alternative pathway is of particular importance in the non-
immune host ; in the early phase of invasive infection with capsulated bacteria, 
specific antibodies are absent and therefore antibody-independent activation of 
C3 and the deposition of C3b on the bacterial surface is a major source of opsonic 
activity. The C3b deposited on the bacterial surface can act as a ligand of specific 
receptors on polymorphonuclear leukocytes or macrophages. Activation of C3 
triggers the complement cascade leading to the formation of the MAC (membrane 
attack complex), whose fixation on the surface of the bacteria can cause 
bacteriolysis. Factor H is a complement regulatory protein which competes for 
surface bound C3b with factor B (Fearon 1978) and facilitates the degradation of 
C3b by factor I. This disassembly of the C3 convertase terminates the C3b 
amplification loop and limits the deposition of this important opsonin on the 
bacterial surface. Bacterial capsules have evolved to take advantage of this 
competition between factor B, which promotes amplification and factor H, which 
terminates it. This has been best studied in type Ill , group B streptococci (Edwards 
et al. , 1982) and in the K1-encapsulated E. coli (Stevens et al. , 1978). Both 
1 8 
capsules contain sialic acid , which increases the affinity of factor H for cell-bound 
C3b. A similar strategy of limiting complement deposition has been described for 
capsules that do not contain sialic acid. The capsules of type 7 and type 12 
pneumococci have a decreased binding affinity for factor B, which results in a 
relative increase in the binding of factor H (Joiner et al. , 1984). The streptococcal 
M protein, a surface fibrillar molecule has a high affinity for factor H and thereby 
evades killing mediated by the alternative pathway (Horstmann et al. , 1988 ). 
Masking of microorganism binding receptors for opson ic factors by the 
capsular layer has also been suggested. Capsule may be permeable to opsonic 
factors that recognize sites beneath the capsular surface, but th is structure may 
present a physical barrier that prevents the opsonic ligand from contacting the 
phagocytic cell (Horowitz and Silverstein , 1980; Horowitz, 1982). Verbrugh et al. 
(1982) showed that lgG from nonimmune serum and C3 were deposited beneath 
the capsule of Staphylococcus aureus and evidently were blocked from interacting 
with the receptors on the phagocytic cells: anticapsular antibody promoted C3 
deposition throughout the capsu le, including the bacterial surface, and resulted in 
efficient opsonization and phagocytosis. 
The onset of the immune response can drastically increase the efficacy of 
the host defense.There are , however, situations in which the immune state of the 
host vis-a-vis an infecting microorganism is virtually never reached and 
susceptibility to infection is maintained in late stages of an infection. Well known 
examples are extraintestinal infections with E. coli exhibiting the K1- or K5-
specific capsular polysaccharides. This is because the structure of K1 
polysaccharide is identical with the terminal carbohydrate region (Finne, 1982; 
Hoffmann et al. , 1982) of the embryonic form of the neural cel l adhesion molecule. 
Similarly, the structu re of the K5 polysaccharide is identical with the first polymeric 
intermediate in the biosynthesis of heparin (Navia et al. , 1983). A similar example 
of structural mimicry has been reported with Mycoplasma mycoides subsp. 
mycoides . It has been suggested that the mycoplasma galactan possesses 
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serological similarity to pneumogalactan, a product of the normal lung epithe lial 
cells (Gourlay and Shifrine, 1966; Shifrine and Gourlay, 1965). Structural analysis 
of the capsular K4 antigen (Rodriguez et al. , 1988) revealed that this 
polysaccharide had the structure of chondroitin, substituted by fructose . This 
fructose substituent, which was found to be the immunodominant sugar of the K4 
polysaccharide , occurs in such a labile linkage that it is removed at pH 4.0 at 37 C. 
In buffered cultures of E. coli 05:K4:H4, the polysaccharide capsule was found to 
lose its fructose constituent with the conversion to nonimmunogenic chondroitin. 
Thus, growth of this E. coli strain in body compartments of low pH may convert 
encapsulated bacteria from a form in which they induce and react with specific 
anticapsular antibodies to a form in which they can no longer do so. 
Since efficient phagocytosis requires the presence of specific anticapsular 
antibody, opsonization of encapsulted bacteria can be hampered by poor 
immunogenicty of the CPS. 
Types of immunological responses 
Specific immune responses are classified into two types, based on the 
components of the immune system that mediate the response: Humeral immunity 
and cell-mediated immunity. 
Exposure of the immune system to foreign antigens sets into motion the 
series of events that lead to lymphocyte activation and the generation of humeral 
and cell-mediated immunity. Different antigens and conditions of immunization 
lead to responses that vary both quantitatively and qualitatively. The magnitude of 
an immune response to an antigen is determined by a balance between 
lymphocyte activation and tolerance induced by that antigen. In fact, the same 
antigen can be administered in ways that preferentially stimulate lymphocyte 
growth and differentiation or inactivate lymphocytes and induce functional 
unresponsiveness. The nature of an immune response to an antigen is 
20 
determined by the specificities and functional classes of lymphocytes that are 
activated by that antigen. For instance, different antigens preferentially stimulate 
the production of antibodies of various heavy chain isotypes or generate CTLs or 
other effectors of cell-mediated immunity. Such variability is important because it 
enables the immune system to protect an individual from the many distinct types of 
microbes present in the environment. 
Antigens being the obligatory first signal for lymphocyte activation , the 
nature of the antigen has significant influence on the type and magnitude of the 
immune response that develops. 
Classi fication of antigens 
One of the important findings leading to the discovery of T and B cells was 
the realization that most antigens required both cell types for induction of an 
antibody response. It was soon found that this was not the case with all antigens. 
Thus, LPS ( Moller et al. , 1971 ) and polyvinylpyrrolidone (Andersson et al. , 1971 ) 
could induce an immune response without the help of T cells. On this basis, 
antigens were classified into two major classes: thymus dependent (TO) and 
thymus independent (Tl). 
Thymus dependent (TD) antigens consist of soluble proteins such as 
hemocyanin , ovalbumin, bovine gamma globulin , haptenated derivatives or 
bacterial proteins such as tetanus and diphtheria toxoids or whole cells, viruses or 
parasites. They require the presence of mature T lymphocytes , which have been 
procesed by the thymus gland, as well as antigen presenting cells. 
Antigens were classified as thymus independent (Tl) because they were 
able to elicit responses in congenitally athymic nude mice or in adult mice who 
had been thymectomized in the newborn period. Thus these antigens do not 
require the presence of the thymus or mature T lymphocytes to stimulate an 
antibody response. However, their behaviour as Tl antigens does not mean that 
they cannot be influenced by T cells, either directly or by cytokines produced by 
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the T cells (Mangini et al. , 1981 ). A common characteristic of these molecules was 
that they consisted of repeated antigenic determinants. This property was 
considered to explain their T-cell independency: the repeating antigenic 
determinants should result in an effi cient crosslinking of the immunoglobulin 
membrane receptors on the B cells and this should give activation signals to the B 
cells. This is the view held by majority of the immunologists today. However, two 
other views on the nature of Tl antigens have been proposed. One is simply to 
deny their existence: Tl antigens are only less T-cell dependent than other 
antigens (Cohn et al. , 1975). The other view is that all Tl antigens are polyclonal B 
cel l activators and this triggers B cells that have bound the antigen by their specific 
immunoglobulin receptors (Coutinho et al. , 1974). 
There are two types of Tl antigens (Mosier et al. , 1982). This classification 
was based on the observations that neonatal mice (Mosier and Zaldivar et al. , 
1977) and mice linked with an X-linked genetic defect such as the CBA/N mouse 
strain (Amsbaugh et al. , 1972) failed to respond to soluble capsular 
polysaccharides but did respond to other Tl antigens. When the properties of the 
group of Tl antigens which could stimulate CBA/N spleen cells (TNP-BA, TNP-
LPS , high epitope TNP-beads) were further analyzed, it became clear that these 
antigens were dissimilar in many respects. Whereas in vitro responsiveness of 
cells to TNP-BA and TNP-LPS was acquired at birth (Mosier et al. , 1977), 
responsiveness to high epitope bead was acquired at 2 to 3 weeks of age (Mand 
et al. , 1979) and in this regard was similar to acquisition of responsiveness to 
TNP-Ficoll (Mosier et al. , 1977). Furthermore, TNP-BA (Mand, 1982) and TNP-LPS 
(Wong and Herscowitz, 1979) were found to be macrophage independent 
antigens while TNP-polyacrylamide beads (Mand, 1982) were found to be 
macrophage dependent. Although experiments in vitro utilizing spleen cells from 
nu/nu mice indicated that TNP-Ficoll behaved as a Tl antigen, rigorous depletion 
of T cells from spleen cells of euthymic mice resulted in the abrogation of the 
response to the antigen and this response was reconstitutable with purified 
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populations of T lymphocytes (Mand, 1982). Thus, Tl-1 antigens require least 
amout of T cell help and can elicit responses in CBA/N mice as wel l as in neonatal 
mice. The Tl-2 antigens, on the other hand, are unable to stimulate B lymphocytes 
without ancillary help. Despite this , these antigens cannot be regarded as TD 
antigens since they do stimulate responses in nude mice. 
Type 1 Tl antigens are bacterial products, tend to have lipids attached, 
function as polyclonal activators in the mouse, activate the alternate complement 
pathway and stimulate responses in the neonates and the xid mice; type 2 
antigens tend to be high-molecular-weight polymers with repeating determinants 
and cannot stimulate responses in the neonates or the xid mice. Examples of type 
1 Tl antigens would include lipopolysaccharide and haptenated derivatives , 
Bruce/la abortus and haptenated derivatives , Nocardia water-soluble mitogen 
and haptenated derivatives, polymerized flagellin from Salmonella bacteria, N. 
meningitidis heat-killed bacteria and outer membrane proteins. Examples of type 2 
Tl antigens would include ficoll and haptenated derivatives, levan, dextran and 
haptenated derivatives, Pneumococcal polysaccharides, H. influenzae 
polysaccharides, N. meningitidis polysaccharides and polynucleotides such as 
poly I- poly C ( Howard et al. , 1971 ; Feldman et al. , 1971; Miranda, 1972) 
In practice, the assignment of a given antigen to the Tl class always is the 
result of a negative experiment (the best available method of T-lymphocyte 
depletion fails significantly to reduce the immune response to the antigen) , so it is 
always formally possible that a Tl antigen will later be reclassified as TD but not 
vice versa. 
Immunological tolerance 
Tolerance (or immunological unresponsiveness) can be defined as a 
specific depression of the immune response induced by previous exposure to the 
antigen. This definition would implicitly exclude genetically controlled inability to 
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respond or an inherent non-immunogenicity of a particular material. Thus, 
tolerance represents an induced depression in the response of an animal that, 
had it not been subjected to the tolerance inducing procedure, would be 
competent to mount an immune response to the antigen being studied. It follows 
from this definition that any formal experimental demonstration of tolerance 
requires two exposures to the antigen : an initial tolerance-inducing exposure and 
a subsequent "challenge" with the antigen presented under appropriate 
immunizing conditions. Tolerance would be assayed as a depression of the 
immune responses of the subjects that received both the tolerance-inducing and 
challenge exposure to the antigen as compared with the responses of subjects 
that received only the challenge. Tolerance can be either complete , that is no 
detectable antibody synthesis , or partial , that is, a quantitatively reduced immune 
response. 
Tl antigens have been known to possess the ability to tolerize B cells. The 
characteristics of Tl antigens that make them potential tolerogens are the 
polymeric structures with repeating determinants , thei r high molecular weight and 
their slow metabolism in the host's body. 
The first step in immunity or tolerance at the cellular level is the binding of 
antigen to immunoglobulin receptors on the cell. In their studies with hapten-
coupled Tl antigens, Wilson & Feldmann (1973) and Klaus (1975) established that 
these antigens, unlike TD antigens, rapidly establish high-avidity binding to B 
cells, because of multipoint attachment of their repeating antigenic determinants. 
The epitope density is a major facto r in causing tolerance (Feldmann, 1972; 
Desaymard & Feldmann, 1975). They found that lightly substituted antigens (with 
0.6 - 2 epitopes /50,000 molecular weight) were immunogenic but not tolerogenic; 
molecules with 2 -3 epitopes per 50,000 molecular weight were both 
immunogenic and tolerogenic; while those with even higher epitope density are 
obligate tolerogens. However, even lightly substituted antigen (0.6 
epitopes/50 ,000 molecular weight) was as effective as were preparations with a 
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four-fold higher epitope density in tolerizing primed B cells (Klaus & Humphrey, 
1975). Based on these observation together with the observations that low doses 
of the antigen were required to tolerize these cells (Klaus & Humphrey, 1975), the 
authors suggested that primed B cells have receptors with higher avidity for 
antigen than the virgin cells and thus the population of memory B cells from 
primed adult mice can be tolerized more easily than can the population of 
potentially responsive mature B cells in unprimed mice. 
Tl antigens are generally high molecular weight and have long chains, as 
distinct from the globular nature of TD antigens.The Tl antigens must be above a 
critical size to function as tolerogens. For example, the tolerogenicity of dextran 
8512 disappears when its molecular weight is reduced from 70,000 to 20,000 
(Howard, Vicari and Courtenay, 1975) and that of 82-6-linked polyfructose when 
reduced from 6000 to 3000 . Moreno, Courtenay and Howard (1976) found that 
the fructose polymers were able to retain their activity even when they are cut 
down to much smaller pieces as compared to their glucose counterparts. They 
suggested that this could reflect stronger binding at individual receptor sites. 
Tl antigens characteristically persist in the body for a long time, because of 
the absence of the appropriate catabolic enzymes. The tolerogenicity of D-amino 
acid polymers, in contrast with the corresponding L-polypeptides, has been 
attributed to their nonmetabolizable nature. Persistence is important in induction 
and maintenance of tolerance because it allows high concentrations to be 
sustained in the environment of the ce ll. 
The mechanism of B cell tolerance induction could be due to immobilization 
of receptors under conditions where the B cell is unable to clear such an antigen 
lattice from the membrane (by shedding or endocytosis) , as it would normally do 
during the events leading up to triggering (Klaus, 1976). Alternatively , Sidman & 
Unanue (1975) suggested that unresponsiveness may result from an intracellular 
inhibition of receptor resynthesis , following receptor modulation by persisting 
antigen. 
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Immune response to bacterial polysaccharides 
Ontogeny 
One of the major problems in developing effective vaccines for the 
prevention of diseases caused by encapsulated bacteria such as S. pneumoniae, 
H. influenzae and N. meningitidis has been the low immunogenicity of their CPS, 
especially in children under 2 years of age who are at greatest risk for infection 
with these bacteria. Normal infants under 2 years have a low and inconsistent 
antibody response to the polyvalent pneumococcal polysaccharide vaccine 
compared to older children and adults (Borgono et al. , 1978; Cowan et al. , 1980; 
Sell et al. , 1981 ). Cowan et al (1980) showed that antibody titers achieved in 
infants immunized before 23 months of age were not statistically different from 
infants receiving saline control. Sell et al (1981) demonstrated that the polyvalent 
pneumococcal vaccine given at 6 months of age stimulated a low level of antibody 
against S. pneumoniae type 3 and the same vaccine given at 12 months of age 
stimulated low levels of antibody against type 3, 7, 18 and 23. The absolute level 
of antibody achieved, however was far below that expected in normal adults. 
Makela et al. (1977) and Anderson et al. (1977) have demonstrated that the 
antibody response of the polyribose phosphate CPS of H. influenzae type bis 
striking ly age dependent, with adequate levels of postimmunization antibody 
being achieved only with vaccination after the age of 18-24 months. Gold et al. 
(1978) and Wi lkins et al. (1979) found the similar age-dependent acquisition of 
antibody responsiveness with meningococcal group A and group C 
polysaccharides. 
This hyporesponsiveness in infants has been shown to be re lated to the 
ontogeny of the response to Tl-2 antigens. While responses to TD antigens are 
present at birth , the responses to Tl antigens are not. Responses to Tl-1 antigens 
could be seen very early whereas responses to Tl-2 antigens could be seen only 
26 
3-18 months after birth in humans and 3-6 weeks in mice. Another difference 
observed between Tl-1 and Tl-2 antigens was that the adult CBNN mice and the 
normal neonatal mice could respond to Tl-1 but not to Tl-2 antigens. This 
unresponsiveness of xid mice to Tl-2 antigens could be corrected by the transfer of 
B cells from normal , genetically compatible strains. In addition, reconstruction of 
thymectomized X-irradiated xid mice with stem cells from normal donors allows the 
recipients to respond to Tl-2 antigens. Both these results (Scher et al., 1975) 
indicated that the mutant xid gene led to B-cell unresponsiveness because of a 
defect within the B cells or their precursors.Thus the dichotomy observed between 
Tl-1 and Tl-2 antigens reflects the differing sensitivities of B-cell subsets at various 
stages of differentiation, the Tl-1-sensitive B cell being an early appearing subset 
and the Tl-2-sensitive subset being a more mature B cell. It was found that the xid 
mice lacked a subset of B lymphocytes characterized by the Lyb-3 (Huber et al. , 
1977) and Lyb-5 cell surface markers (Ahmed et al. , 1977). These cells 
(designated Lyb-5+ B cells) are present at low frequencies in 2-week-old normal 
mice and do not reach adult levels until 3-4 weeks of age. In both neonatal mice 
and mice with xid defect, the failure to respond to polysaccharide antigens 
correlates with an absence or diminished number of this mature subset of B cel ls 
(Mosier et al. , 1977). Boswell et al (1980) demonstrated the requirement for Lyb-5+ 
B cells in the in vitro antibody response to the type 2 Tl antigen, trinitrophenylated-
Ficoll (TNP-Ficoll) . 
The utilization of cyclosporin A reinforced the notion that the B lymphocytes 
can be subdivided into two distinct subsets. Kunkl et al (1980) reported that the 
administration of cyclosporin A to mice along with antigens blocks the response to 
Tl-2 antigens, leaving the capacity to respond to type 1 Tl antigens intact. 
Memory and affinity 
A significant feature that accompanies the response to a TD antigen is the 
development of memory cells. Memory B cells (Klinman et al. , 1990) are primed 
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and respond rapidly to a second dose of antigen, resulting in a secondary 
antibody response that occurs sooner than the primary, is shifted to a higher 
proportion of lgG than in the primary, and overall is of higher magnitude, usually 
10-fold (Stein et al. , 1990). In the case of protein antigens or haptens coupled to a 
protein carrier, the secondary antibodies are of higher affinity than the primary 
antibodies (Berek et al. , 1988; Stein et al. , 1980), which is thought to result from 
antigen selection of antibodies that have undergone somatic hypermutation 
(Manser et al. , 1990). In contrast, a second dose of a Tl antigen stimulates a 
response that is not increased compared to the primary response or is increased 
only by a small amount , two- to fourfold at most (Stein et al. , 1990). In general, the 
affinities of antibodies to polysaccharides are two orders of magnitude lower than 
affinities of antibodies to proteins or haptens and there is little or no evidence of 
affinity maturation . The question of whether antibodies to polysaccharides 
stimulated by a TD form of the polysaccharide undergo affinity maturation has not 
been satisfactorily answered. 
Class. subclass and combininQ site 
For essential ly all humoral immune responses , both lgM and lgG antibodies 
are produced and represent the major classes. The secondary response to TD 
antigens is accompanied by an increase in the ratio of lgG to lgM, whereas for Tl 
antigens usually both isotypes are produced in relatively low amounts and in a 
one-to-one ratio that changes very little with a secondary immunization (Stein et 
al. , 1982; Stein et al. , 1990) 
In both mice and humans, the predominant subclass in response to a TD 
antigen is lgG1 ; however, lgG2 is also produced in reasonable amounts. In mice , 
relatively little lgG3 and in humans relatively little lgG3 and lgG4 are produced in 
response to TD antigens. In contrast, responses to Tl antigens show significant but 
varying degrees of restriction to certain subclasses. In the mouse, lgG3 , normally 
expressed at low levels in the serum, is overexpressed among antibodies to 
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polysaccharide (Stein , 1992). In humans the subclass restriction is not as marked 
as in mice, but there is a restriction to lgG2 that is more evident in sera from 
immunized adults (Shackelford et al. , 1988; Shackelford et al., 1987; Rautonen et 
al. , 1986). 
Mice with xid-determined xid defect have normal levels of serum 
immunoglobulins except that lgM levels are moderately depressed (Perlmutter et 
al. , 1979). This, along with the observation that antibodies produced in response 
to Tl-2 antigens are primarily of lgM and lgG3 classes, has led to the suggestion 
that lgG3 production is largely a property of antibody forming cells which develop 
from Lyb5+ B cells (Kung et al. , 1983). Since, Tl-1 antigens yield lgG responses in 
which lgG1 or lgG2 predominate, Kung et al (1983) suggested the possibility that 
when Lyb5+ B cells are activated by Tl-2 antigens, a form of lg switching leading to 
major expression of lgG3 predominates and that Lyb5- B cells do not use this 
switching pathway. Consequently, lgG3 is a minor fraction of the lgG that is 
secreted by the Lyb5- lineage. 
Responses to protein antigens are polyclonal, probably reflecting the many 
unique epitopes on these molecules. Polysaccharide antigens, in contrast, are 
large molecules with repeating determinants and relative ly few epitopes. 
Antibodies to polysaccharides have been found to be oligoclonal rather than 
polyclonal (Hansburg et al. , 1979). Studies of TD forms of po lysaccharide have 
shown that the response is oligoclonal, resembling the Tl response; however 
some diversity is observed (Stein et al. , 1982; lnsel et al. , 1986). 
Natural Immunity to polysaccharides 
It has been observed that most adult animal sera contain antibodies to 
polysaccharide antigens of various pathogenic bacteria. Antibodies to pathogenic 
organisms, e.g. meningococcal group A, B, C, H. influenzae type band 
pneumococcal type 3 were detected in the animals as they grew or in human 
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adults without possible contact with these organisms (Robbins et al., 1975; Sutliff 
and Davies, 1937). Goldschneider et al (1973) found that there was an age-
related increase in natural antibodies to the group A meningococcal 
polysaccharide in children even though the group A organisms were rare ly 
isolated from them. Sell et al (1981 ), during their study of responses to polyvalent 
pneumococcal vaccine in infants , found that natural acquisiti on of type specific 
antibody occurred in the unvaccinated controls such that by 24 months of age, 
mean antibody titers of the vaccinated and the unvaccinated groups were not 
different. On the basis of serological studies, the possible antigenic sources for 
these serum protective antibodies were identified to be derived from the cross-
reactive antigens (capsular polysaccharides) among intestinal and pharyngeal 
bacteria (Schneerson and Robbins, 1975 ; Robbins, 1978). This was later 
confirmed by the recognition of structural simi larities between the capsular 
polysaccharides of various organisms. Bax et al (1988) showed that the capsular 
polysaccharide of N. meningitidis group A cross-reacts with the capsules of E. coli 
K93, E. coli K51 and Bacillus pumilis, bacteria that are frequently found in human 
flora. Similarly , the CPS of N. meningitidis group B cross-reacts with E. coli K1 ; 
CPS of N. meningitidis group C with E. coli K92 and the CPS of H. influenzae 
type b with the CPS of E. coli K100 (Egan et al., 1980). The one exception to the 
rule that structural similarities form the basis of cross-reacting determinants is the 
polysaccharide of E. co li K93 which although being highly cross-reactive with the 
group A meningococcal polysaccharide, does not share with it one single common 
glycose residue or linkage (Bax et al. , 1988) . The probable explanation is that the 
common determinant can be recognized by comparing the two dimension 
structures of these two polysaccharides (Jennings, 1990). This phenomenon of 
serological cross-reactions being involved in the human immune mechanism to 
pathogenic bacteria has been clearly demonstrated by Schneerson and 
Robbinson (1975). On deliberately feeding non-pathogenic E. coli possessing the 
K100 capsule to human-adult volunteers, they found that intestinal colonizat ion 
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readily occurred and antibodies specific for the H. influenzae type b 
polysaccharide were induced. 
T cell regulation of the magnitude of Ab response 
While Tl antigens do not require helper T cells for induction of an antibody 
response, the magnitude of the response may be influenced by suppressor T cells 
and amplifier B cells. Baker et al (1970) reached this conclusion when they 
observed that the treatment of thymus bearing mice with antilymphocyte serum 
(ALS) enhanced the level of response to type 3 pneumococcal 
polysaccharide.This enhancement could be reversed by transfer of lymphocytes to 
ALS-treated mice indicati ng the T cell natu re of the suppression. However, the 
ALS-induced enhancement is not demonstrable in athymic nude mice suggesting 
that at least a subset of T cells are required for the expression of ALS-induced 
enhancement. Based on these findings the authors proposed that the antibody 
response to type 3 pneumococcal polysaccharides were controlled by the 
activities of 2 kinds of regulatory T cells called suppressor T cells (Ts) and 
amplifier T cells (Ta). Ts limit the extent to which antibody forming T cells 
proliferate in response to the antigen, whereas Ta drive B cells to multiply further 
after antigenic stimulation. 
Markham et al (1977), Taylor and Amsbaugh et al (1983), Taylor and 
Stashak et al (1983) and Taylor et al (1984) deleted Ts or Ta activity from donor 
cell suspensions by treatment with appropriate anti-CDS or anti-CD4 monoclonal 
antibody and complement (since Ts are CD8+CD4- and Ta are CD8-CD4+). They 
found that on transfe rring cell suspensions containing both Ts and Ta activity to 
athymic mice immunized with type 3 pneumococcal polysaccharide , the resulting 
anti-polysaccharide response is not changed. On the other hand, if Ta activity was 
eliminated before cell transfer, significant suppression of the response occurred 
whereas elimination of Ts activity resulted in increased response. Thus, Ts and Ta 
act in a competitive manner on B cells to control the magnitude of the antibody 
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response elicited after immunization. 
Taylor and Stashak et al {1983) showed that the B cells from mice 
immunized with type 3 pneumococcal polysaccharide activated antigen-specific 
Ts cells. Later, Elkins et al {1987) showed that the antigen primed B cells must 
express cell-surface lgM, but not lgD la antigen to be able to activate Ts cells. 
Elkins et al showed that antigen-primed B cells that were y-irradiated retained the 
ability to activate Ts whereas UV treated cells failed to do so. Both y-i rradiated and 
UV treated antigen-primed B cells expressed comparable levels of cell-surface 
lgM and localized to the spleen after in vivo transfer. Neither of the two could 
proliferate in response to the mitogens. By contrast , y-irradiated primed B cells 
could synthesize proteins whereas the UV treated could not. On the basis of these 
findings , the authors suggested that metabolic activity is necessary for activation of 
Ts cell by the primed B cells. Taylor et al (1989) showed that similar T cell 
regulation via Ts and Ta cells occurs with P. aeruginosa lipopolysaccharide, S. 
mutans polysaccharide and meningococcal polysaccharide and also H. 
influenzae type b polysaccharide. 
Studies on the ontogeny of Ts and Ta activity (Morse et al. , 1976) for the 
antibody response to type 3 pneumococcal polysaccharide revealed that Ts 
activity emerges first and is fully developed at 2 weeks of age. Ta activity, on the 
other hand, is minimal until week 4 and does not reach adult level until 8 -1 0 
weeks of age. Furthermore, the immaturity of B ce ll subpopulations in terms of la 
density and Lyb-5 marker, would correlate with the inability of mice younger than 
3-4 weeks of age to mount antibody responses to many Tl antigens. 
Role of spleen in immune response to polysaccharides 
Studies in patients before and after splenectomy, patients with functional 
and anatomical asplenia and animal experiments (Maclennan et al. , 1986; Amiot 
et al. , 1985; Amiot and Hayes, 1985; Cohn et al., 1987; Wara D. , 1981) have 
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shown that the Tl-2 antigen-related immune response is specifically related to the 
spleen. The presence of spleen seems to be important in the primary encounter of 
the antigen whereas the secondary responses can also take place at sites outside 
the spleen. This has led to the suggestion that in the spleen , specific subsets of B 
cells are present or that B cells can only be triggered to respond to these types of 
antigens in a splenic microenvironment. In the marginal zone (MZ) , where the 
blood leaves the arterial system into the venous sinuses, a special type of 
macrophages known as the marginal zone macrophages are present. By labelling 
the various polysaccharides with radioiodine and studying the autoradiographs, 
Humphrey, J.H. (1981) showed that the uncharged polysaccharides were 
exclusively taken up by the MZ macrophages and the acidic polysaccharides were 
mostly concentrated in the red pulp macrophages of mice. Kraal et al (1988), by 
using specific monoclonal antibodies found a much reduced MZ and thin and 
partly absent rings of MZ macrophages in the CBNN mice (xid mice) which could 
explain the unresponsiveness of these mice to polysaccharides. On the basis of 
these results it was suggested that the MZ macrophages perhaps presented the 
polysaccharides to the lymphocytes. However, the findings of Kraal et al (1989) 
question the role of MZ macrophages in the immune response to polysaccharides. 
Injection of a monoclonal antibody which reacted specifically with the mouse MZ 
macrophages resulted in complete abrogation of the uptake of neutral 
polysaccharides by the cells in vivo but this did not result in an altered humoral 
immune response to the polysaccharide (TNP-Ficoll). Even when the MZ 
macrophages were completely eliminated by coupling the antibody with a toxin -
gelonin , there was no alteration in the immune response against TNP-Ficoll. This 
would suggest that either the MZ macrophages are not involved in this kind of 
response or their function can be taken over by other cells. 
In the MZ, a special type of B cell has been described by Bazin et al., 1982). 
These B cells express low levels of lgD and high levels of lgM, are intermediate in 
size, do not recirculate and are thought to represent a separate lineage in B cell 
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development restricted to the spleen. Ti mens et al (1989) studied the splenic MZ 
in infants. Whereas all other cellular compartments completed their maturation to 
an adult immunophenotype and morphology within the first 5 months, the MZ B 
cells showed different features compared to the adult MZ B cells. The infant MZ B 
cells had a very high percentage of cells coexpressing lgM and lgD but there was 
an essential lack of CD21 antigen expression. Thus the authors suggested that the 
hyporesponsiveness of infants to polysaccharides could probably be due to the 
immaturity of the splenic MZ. 
Helen Braley Mullen (1990) attempted to study the properties of the 
antigen-presenting cell that would be required for activation of pneumococcal 
polysaccharide type 3 (Siii) specific suppressor T cells and contrasuppressor T 
(Tes; Baker et al. , 1988) cells by coupling Siii to various spleen cell 
subpopulations and assessing the ability of these Siii-spieen cells to activate Ts 
and Tes. The results indicated that Ts and Tes are preferentially activated when 
Siii is presented on distinct cell types. Siii-specific Ts were activated when Siii was 
coupled to anti-1-J reactive (Malley et al. , 1987) plastic adherent cells, presumably 
macrophages and Tes were activated when Siii was coupled to 1-J negative, 
plastic non-adherent spleen cells. 
Thus, immunity to diseases caused by invasive, encapsulated bacteria is 
associated with the presence of antibodies to the capsular polysaccharide. 
Hu moral response to these bacterial polysaccharides is characterized by 1) 
production of predominantly lgM isotype antibody; 2) lack of a booster response ; 
3) delay in ontogeny; 4) lgG subclass restriction. 
Immunity to mycoplasma polysaccharides 
Mycoplasma mycoides subsp. mycoides, the causal agent of contagious 
bovine pleuropneumonia synthesizes a galactan that forms a slime layer. Buttery 
et al (1975) reported that an intravenous injection of galactan exerted specific 
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effects on the vascular system of the lung and on respiration which were 
manifested as transient apnoea, increased pulmonary arterial and decreased 
systemic arterial blood pressure. Necropsy revealed hemorrhages associated with 
alveolar ducts and vessel walls , areas of pulmonary edema, dilated airways and 
also some capillary thrombosis. The authors suggested that the galactan may 
have caused the release of biogenic amines which may have produced the effects 
seen. Out of the 8 calf sera that were tested , only three agglutinated galactan-
coated goat red blood cells, one at a dilution of less than 1 in 80 and the other two 
at dilutions greater than 1 in 80. One interesting observation was that none of the 
calves showed any kind of reaction when they were injected for the second time 
with galactan using the same dose as the first time or even up to five times the first 
dose. The authors suggested two possible explanations for th is phenomenon. 
First, it could be possible that galactan caused a release , to the extent of depletion , 
of a cell-bound mediator. The second possibility is that galactan binds for a long 
time with the cell receptor so that the receptor was not available for a second dose 
of galactan. 
Several investigators have attempted to measure antibody responses to M. 
dispar antigens in the sera and lung washings from several groups of naturally or 
experimentally infected cattle. Scott et al (1980) examined the sera from five 
groups of eight calves selected from a herd reared on a beef unit in Southern 
England. Sera taken from these animals at about monthly intervals over a period 
of 200 days were examined for lgG antibody to M. dispar by enzyme-linked 
immunosorbent assay. A very small increase in the mean antibody titer of two out 
of the five groups was observed. Thomas et al (1982) examined paired sera , the 
first sample being taken at the onset of outbreaks of respiratory disease and the 
second about thirty days later. A fourfold increase in the lgG antibody was seen in 
a few of these animals. Another group of sera was examined from Ayrshire calves 
(Howard, 1983) . These calves had pneumonic lesions and were colonized with 
M. dispar. Although no serum antibody was detected, significant levels of lgA 
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antibodies to M. dispar were detected in the lung washings by ELISA. Howard 
and Gourlay (1983) reported that vaccination of gnotobiotic calves with formalin -
killed M. dispar and oil-adjuvant by the intramuscular route followed by 
intratracheal administration of the killed M. dispar failed to protect against 
respiratory challenge with M. dispar. In contrast, three subcutaneous injections 
gave some evidence of protection. The investigators reasoned that the poor 
response to M. dispar could have been due to the destruction of antigens by 
formalin treatment and so they compared the responses to live and formalin-killed 
organisms in conventionally reared Ayrshire calves. They found no evidence for 
live mycoplasmas inducing a better serological response than killed 
mycoplasmas. Thus, M. dispar was found to be very poorly immunogenic. They 
also studied the serological response (lgM and lgG1 by single radial hemolysis) in 
conventionally reared calves of varying ages following three subcutaneous 
injections of M. dispar antigen. They found that the response was poorest in 
young calves and greatest in oldest calves. Almeida et al (1992) investigated the 
effects of encapsulated M. dispar and purified capsule of M. dispar on the activity 
of bovine alveolar macrophages, in vitro. They reported that the encapsulated M. 
dispar and the purified capsule, as opposed to unencapsulated M. dispar, did 
not induce and suppressed the production of tumor necrosis factor , interleukin-1 
and glucose consumption by the alveolar macrophages. Thus, the very low 
antibody responses produced towards M. dispar, as reported by Howard and 
Gourlay (1983) could have been due to suppressive effects of M. dispar capsular 
material on the macrophages. 
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IMMUNE RESPONSES TO THE CAPSULAR POLYSACCHARIDE OF 
MYCOPLASMA DISPAR IN CALVES AND MICE 
A paper to be submitted to Comparative Immunology, Microbiology and Infectious 
Diseases 
Praveen Bansal and R. F. Rosen bu sch 
Abstract --- Humeral and cell-mediated immune responses to the capsular 
polysaccharide (CPS) of M. dispar and polygalacturonic acid (pGalU - a 
structurally similar polysaccharide) were investigated in calves experimentally 
infected with M. dispar and in mice immunized with CPS or pGalU. Sera, 
tracheobronchial lavage and nasal fluids, collected befo re and after infection in 
calves , were checked for the presence of anti-CPS and anti-pGalU antibodies. 
The sera from mice injected with CPS or pGalU were checked for different classes 
of anti-CPS and anti-pGalU antibodies. Peripheral blood lymphocytes from calves 
and splenic lymphocytes from mice were monitored for specific proliferative 
responses to CPS and pGalU. At about 2 weeks post-infection , anti-CPS lgM 
response in serum, anti-CPS and anti-pGalU lgM and lgA response in lavage fluid 
and lymphocyte proliferative response was seen in the calves. Mice immunized 
with CPS and pGalU gave exclusively lgM responses. No secondary response 
was seen in mice immunized with CPS in contrast to mice immunized with pGalU. 
Antibodies cross-reactive with pGalU were present in the sera of CPS-immunized 
mice but antibodies cross-reactive with CPS were not found in pGalU-immunized 
mice. No significant blastogenic response was shown by mouse splenocytes to 
CPS or pGalU. 
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INTRODUCTION 
Mycoplasma dispar is a capsulated mycoplasma which establishes chronic 
infection of the lower respiratory tract in calves resulting in local 
immunosuppression [1] and specific lesion production [19) . The capsular 
polysaccharide (CPS) is produced by the mycoplasma during natural infections [7] 
and in vitro, under conditions of co-culture with bovine lung fibroblasts [2] . This 
CPS has been shown to be involved in the suppression of several alveolar 
macrophage functions such as tumor necrosis factor and interleukin-1 production 
[1 ]. Thus, the CPS appears to be a major virulence factor. Acidic hydrolysis of the 
CPS of M. dispar with 4 M trifluoroacetic acid showed the presence of 
galacturonic acid residues [14) . In order to study the influence of galacturonic acid 
residues on the immunogenicty of the CPS, immune responses to 
polygalacturonic acid (pGalU - a linear homopolymer of galacturonic acid) were 
compared to those obtained against CPS. 
Several attempts have been made to measure antibody responses to M. 
dispar proteinaceous antigens in naturally or experimentally infected cattle [6, 8, 
17, 18) and almost none or very poor antibody responses were seen. Immune 
responses to the capsular antigen, however, have not been studied. This study 
was made to characterize the nature of the immune responses towards the CPS 
and to examine the extent of cross-reactivity among CPS-specific and pGalU-
specific responses. 
MATERIALS AND METHODS 
Cattle 
Three beef-type calves obtained from a Mycoplasma dispar-free herd were 
separated from the cows at birth and placed in individual isolation rooms with 
cedar chip bedding. They were fed limited colostrum (one pint) and a starch-free 
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diet which consisted of powdered skimmed milk supplemented with vitamins and 
minerals. 
Mice 
Inbred, male Balb/c mice were obtained from Taconic, Germantown, NY. They 
were kept in a micro-isolator (Lab Products, Maywood, NJ) on an aspen chip 
bedding and were fed mouse breeder sterilizable diet 7004 (Teklad , Madison , WI). 
Antigens 
The CPS of Mycoplasma dispar was produced and purified according to the 
method of Almeida et al (1], with minor modifications. Briefly, M. dispar cells were 
co-cultured with bovine lung fibroblast monolayers for 23 hours. After separating 
the mycoplasmas from the bovine cells and washing them in PBS three times at 
4°C, capsule was extracted by incubating the mycoplasmas in phosphate-
buffered saline at 37°C for 1 hour. The supernatant obtained after centrifugation 
was lyophilized. This preparation was then purified by capturing the CPS on 
agarose bound Ricinus communis agglutinin I or RCA120, (Vector, Burlingame , 
CA), and eluting with 0.1 M galactose. The eluate was then passed through a 
Biogel P4 (Bio-Rad, Melville, NY) size exclusion column using distilled water as 
the running buffer. Each collected fraction was analyzed for the presence of CPS 
by thin-layer chromatography. A sample of 1 µI of each fraction was spotted on 
silica gel plate (E . Merck, Darmstadt, Germany) and was run in a solvent system of 
butanol, acetic acid and water in the ratio of 2:1 :1 . The carbohydrate spots were 
visualized by dipping the plate in a reagent made up of 0.5 g thymol , 0.5 g a-
naphthol, 5 ml concentrated sulfuric acid and 95 ml ethanol and heating the plate 
for 1 O minutes at 120°c . The fractions that had CPS were pooled and lyophilized. 
The protein and nucleic acid contamination in the purified CPS preparation was 
checked by measuring A2ao and A260· 
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Polygalacturonic acid , sodium salt was obtained from Sigma Chemical Co., 
St. Louis, MO. 
Infection and immunization 
The SD-0 strain of M. dispar used at passage level 10 had been previously 
isolated from a pneumonic calf [19] and cloned twice. The calves were infected by 
intratracheal canulation with 109 cfu of M. dispar strain SD-0 in 50 ml of sterile 
PBS pH 7.4 at the age of 4 weeks. 
Groups of 4 Balb/c mice were injected subcutaneously one or two times, 2 
weeks apart with 0.5 µg of CPS or pGalU using alum as adjuvant (Pierce , 
Rockford , IL). CPS and pGalU were reconstituted in saline to a concentration of 
1.3 µg/ml. Alum was then added to the antigen such that the ratio of alum to alum-
antigen mixture was 1 :4 vol I vol. Each mouse was injected with 0.5 ml of this 
alum-antigen mixture. A group of 4 mice was not injected and was used as the 
non-injected control group. For each group of 4 mice which was injected with 
antigen , there was a group of 2 mice which was injected with the adjuvant alone. 
Collection and processing of samples 
Nasal swabs were taken from each calf twice at weekly intervals pre-infection 
and once after infection. The swabs were dipped in 1 ml of sterile PBS for 30 
minutes and then processed for mycoplasma isolation as has been described 
before [11 ]. 
Nasal fluid and tracheobronchial lavage fluid were collected once before 
infection and twice after infection (12 and 35 post-infection) . Sterile gauze tampon 
prepared to fit a nostril was inserted into one nostril at a time, left in place for 3 
minutes, and then transferred aseptically into a chilled tube . The nasal fluid was 
expressed from the gauze tampon by adding 0.3 ml of PBS and centrifuging . To 
the fluid , 1 mM EDTA was added prior to storage at -20° C. 
For the collection of tracheobronchial lavage fluid , each calf was sedated with 
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Rompun (Miles Laboratories, Shawnee, Kansas) , 1 mg per pound body weight, 
injected intramuscularly. Aseptically , a mid-line skin incission was made mid-way 
down the neck over the trachea, and a 13 gauge cannula inserted into the trachea 
with the aid of a 15 gauge trocar (Tracheal wash kit , Har-Vet, Spring Valley, WI). 
After ascertaining that the cannula was in place (air could be aspirated readily if in 
place) , 50 ml sterile PBS was flushed through the cannula into the 
tracheobronchial passage and then aspirated into a fresh syringe. Approximately 
2 ml of the straw-colored fluid was recovered from each calf. The fluid was 
centrifuged at 700 X g for 5 minutes to remove cells. Two hundred microliters of 
this fluid was processed for mycoplasma isolation [11 ]. EDTA (1 mM) was added to 
the remaining fluid and stored at -20° C. 
Blood for serum and peripheral lymphocytes (20 ml) was collected twice 
before infection and weekly after infection for 5 weeks. Sera were collected and 
stored at -20°C. The peripheral lymphocytes were processed for lymphocyte 
proliferation assay. 
The sera, alveolar lavage fluid and nasal fluid were examined for the 
presence of anti -CPS and anti-pGalU lgG, lgM and lgA antibodies by ELISA. To 
measure antibodies in the lavage flu id, it was treated with an equal volume of 
1:100 Sputolysin (Calbiochem , San Diego, CA) for 60 minutes at room 
temperature and centrifuged to remove the mucus. 
The calves were euthanized 35 days post-infection. Bronchiolar swabs were 
taken at post-mortem using a pediatric swab with calcium alginate fiber tip (Fisher, 
Itasca, IL) for isolation of M. dispar. 
Groups of mice were killed by C02 asphyxiation, bled by heart puncture and 
their spleens removed 3, 5, 9, and 12 days after the first injection, or 3, 5 and 7 
days after the second injection. Prior to immunization, al l mice were bled by retro-
orbital puncture. The serum samples were examined for the presence of anti-CPS 
and anti -pGalU lgM, lgA, lgG1, lgG2a , lgG2b and lgG3 antibodies by ELISA. 
Spleens were processed for splenic lymphocyte proliferation assays. 
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ELISA 
The assay was performed using 96 well , flat bottom plates (lmmunolon I, 
Dynatech, Chantily, VA). The plates were incubated stationary with 100 µI of 
Ricinus Communis Agglutinin RCA120 (Sigma, St. Louis, MO) diluted at 500 ng/ ml 
in 0.1 M sodium carbonate for 14 hrs at 37°C. The plates were then washed once 
with ice-cold PBS and stored at 4°C until used. Just before use, the plates were 
washed three times with ice-cold capsule buffer (Hepes 1 O mM pH 7.5 ; NaCl 0.15 
M; CaCl2 0.1 mM). The carbohydrate , CPS or pGalU (100 ng) dissolved in 100 µI 
of capsule buffer, was then added to each well and incubation allowed for 1 hour 
at room temperatu re. The plates were then washed three times with ice-cold 
capsule buffer supplemented with 0.5% horse serum (CBHS). The coated wells 
were then incubated at 37°C for 1 hour with 100 µI of test sera diluted to 1:100 or 
100 µI of tracheobronchial lavage fluid and nasal flu id diluted to 1:10 with CBHS. 
Tests were set up in duplicate. Plates were washed three times with CBHS and 
then incubated with 100 µI of a 1 :400 dilution in CBHS of rabbit anti bovine lgG, 
lgM, lgA (Cappel, Malvern , PA), for 1 hour at 37°C. The plates were washed again 
three times with CBHS and 100 µI of horseradish peroxidase conjugated goat anti 
rabbit lgG (Cappel, Malvern, PA) diluted to 1 :400 with CBHS was added to each 
wel l. The plates were incubated for 1 hour at 37°C and then washed three times 
with CBHS. In the case of murine sera, after the addition of antisera (also diluted 
1:100 with CBHS), the appropriate conjugated goat anti mouse lgM, diluted to 
1 :200 or goat anti mouse lgA, lgG2a, lgG2b or lgG3 labelled with horseradish 
peroxidase (Boehringer Manheim, Indianapolis, IN), all diluted to 1 :400 with 
CBHS, was added to each well and incubation allowed for 1 hour at 37°C, 
followed by three washes with CBHS. The substrate solution was prepared with 
tablets of 5-aminosalicylic acid following manufacturer's instructions ( Sigma, St. 
Louis , MO). After incubation for 20 minutes at room temperature , the reaction was 
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stopped by addition of 100 µI of 3N NaOH and the color obtained was measured 
spectrophotometrically at 550 nm with an automated microplate reader (Model 
EL310, Bio-Tek, Winooski, Vermont). 
The results were expressed as mean ± SEM, where SEM was calculated as 
the standard deviation (SD) divided by the square root of the number of animals. 
The serological cut-off for a positive reaction was taken as the mean plus 2 SD of 
the pre-infection or pre-immunization samples. Thus, a serum was considered 
positive for anti-CPS lgM, anti-pGalU lgM, lgA (both anti-CPS and anti-pGalU) if 
the difference between the pre and post immune sera was greater than 0.020, 
0.032, 0.035 O.D. units at 550nm respectively. 
Peripheral blood lymphocyte proliferation assay (calves) 
Lymphocyte blastogenesis (LB) was done according to the method of Roth et 
al [15] with a minor modification. Briefly, peripheral blood lymphocytes were 
collected by layering diluted blood on Histopaque 1077 (Sigma, St. Louis, MO) 
and centrifuging at 540 G for 40 minutes at room temperature. The hazy band was 
harvested and washed with Hanks balanced salt solution without calcium and 
magnesium (Sigma, St. Louis, MO) and finally the lymphocytes were suspended 
in Medium 199 (GIBCO, Gaithersburg , MD) supplemented with 1000 units/ml 
penicillin , 100 ng/ml kanamycin, 100 ng/ml streptomycin , 15 % fetal calf serum and 
2-mercaptoethanol. The cells were then counted on a Coulter Counter (Model ZF, 
Coulter Electronics, Hialeah , FL) and the cel l count was adjusted to 2.5 x 106 
cells/ml. Two hundred microlitres of the adjusted cell suspension was added in 
triplicate to the wells of a 96 well, flat bottom plate (Costar, Cambridge, MA) . 
Twenty five microlitres of antigen (1.2 mg/ml or 120 µg/ml of pGalU ; 120 µg/ml or 
12 µg/ml of purified CPS), ConA (20 µg/ml) or PBS was added to groups of 3 
replicate wells. The plate was then incubated in a C02 incubator at 37°C for 5 
days. Twenty two hours before harvesting, 0.25 µCi of [3H] thymidine (Amersham, 
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Arlington Heights, IL), contained in 25µ1 of Medium 199 supplemented as above 
was added to each well . The cells were harvested onto water-prewetted glass 
fiber filters. These were then air dried and placed in a vial. To each vial , 5 ml of 
scintillation cocktail (ScintiVerse BO, Fisher, Itasca, IL) was added and the counts 
were done using a liquid scintillation counter (Model 1500, Packard, Downers 
Grove, IL). The stimulation index was calculated by dividing the mean counts per 
minute of triplicate antigen-stimulated cultures by mean counts per minute of 
unstimulated cultures. 
Splenic lymphocyte proliferation assay (mice) 
A cellular proliferation assay was performed with splenocytes, using the T-
lymphocyte mitogen ConA (Sigma, St. Louis , MO) and the B-lymphocyte mitogen 
LPS from E. coli K235 (Sigma, St. Louis, MO) as the positive controls. The assay 
was performed as described by Lysle et al [12], with minor modifications. 
On the appropriate day, the mice were killed by C02 asphyxiation and then 
were immediately bled via heart puncture. The spleen was then immediately 
removed and placed in a polypropylene tube containing 5 ml of RPMl-1640 
medium (GIBCO, Grand Island, NY) which was supplemented with 10 mM Hepes, 
2 mM glutamine and 50 µg gentamicin/ml . 
A single cell suspension of each spleen was prepared by gently pressing the 
tissue between the ends of sterile frosted microscope slides in supplemented 
RPMI enriched with 10% fetal calf serum (RPMI+). The number of splenocytes was 
determined using a Coulter counter (Model Z F, Coulter Electronics, Hialeah , FL) 
and adjusted to 5 X 106/ml. 
The mitogen ConA was made to a concentration of 1.0 µg/mL and LPS to a 
concentration of 10.0 or 5.0 µg/mL in RPMI+. Antigens CPS and pGalU were made 
to a concentration of 0.5 , 5.0 or 50 µg/ml in RPMI+. 
One hundred microlitres of the adjusted cell suspension was added to the 
wells of a 96-well , flat-bottom plate (Costar, Cambridge, MA). Then , 100µ1 of the 
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antigen (CPS or pGalU) or RPMI+ (negative control) or mitogen (ConA or LPS) 
was added to groups of 3 replicate wells and the plates were incubated at 37°C in 
a humidified incubator with 5 % C02. The cultures were pu lsed with 1 µCi (3H] 
thymidine (Amersham, Arlington Heights, IL) in 50 µI of RPMI+ during the last 24 
hours of a 5 day incubation. The cultures were haNested onto glass fiber filters 
using a microharvester (Bellco Glass, Vineland , NJ). The incorporation of [3H] 
thymidine was determined with a liquid scintillation counter ( Model 1500, 
Packard, Downers Grove, IL) and expressed as counts per minute from which the 
stimulation index was calculated. 
Statistical analysis 
Analysis of variance was used to assess the statistical significance of the 
changes in antibody levels after immunization with CPS and pGalU in mice. The 
level of significance for the F test was set at a probability of 0.001 . 
RESULTS 
Mycoplasma isolation 
No M. dispar was isolated from the calves prior to the experimental infection. 
The organism was isolated from the lavage fluid (collected at 12 and 35 days post-
infection) as well as from the lungs of the infected calves at necropsy. 
Antibody responses in M. dispar infected calves 
In the infected calves, no serum lgA or lgG was seen in response to both CPS 
and pGalU (data not shown) . However, there was a significant increase in the anti-
CPS and anti-pGalU lgM level at 14 days post-infection (Fig. 1 ). The increase in 
the anti-pGalU lgM level was much smaller than the increase in the anti-CPS lgM 
level. The tracheobronchial lavage fluid did not show any lgG response and there 
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was a significant lgM and lgA response to both CPS and pGalU 12 days post-
infection (Fig. 2). No significant lgM, lgG or lgA response was seen in the nasal 
fluid (data not shown). 
Antibody responses of the immunized mice 
The mean anti-CPS and anti-pGalU lgM level, measured as absorbance at 
550 nm using ELISA, in the pre-immune sera of mice was 0.025 ± 0.00115 (mean 
± SEM ; n = 78 mice) and 0.051 ± 0.0020 (mean± SEM; n = 78 mice) respectively. 
The mice immunized with 0.5 µg of CPS gave exclusively lgM antibody response 
to CPS which could be seen as early as 3 days, peaked at 9 and declined at 12 
days after the first injection (statistically significant at p < 0.001 ). No antibody 
response was seen after the second injection (Fig. 3). Mice immunized with pGalU 
gave a pGalU-specific lgM response which increased from 3 days to 12 days 
(statistically significant at p < 0.001 ). A secondary anti-pGalU lgM response was 
seen beginning from 3 days and peaking at 5 days after the second pGalU 
injection (Fig. 4). The antibodies in the sera of mice immunized with pGalU did not 
show any cross-reaction with CPS while the antibodies in the sera of mice 
immunized with CPS did show cross-reaction with pGalU. This cross-reactive 
response could be seen as early as 3 days, peaked at 5 days and declined from 
then onwards. However, no cross-reactive antibodies were seen after the second 
injection of CPS (Fig. 4). 
Lymphocyte proliferation 
The peripheral blood lymphocytes from infected calves showed a 1.66-fold 
increase in the stimulation index on day 14 post-infection when stimulated with 
CPS at a concentration of 12 µg I ml (Fig . 5). No significant proliferative response 
was seen with other doses of CPS or to any dose of pGalU. No significant 
increase in the stimulation index of mice splenocytes was observed with any dose 
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of CPS or pGalU (Fig. 6). 
DISCUSSION 
A study to assess the immune responses produced towards the CPS of M. 
dispar in calves experimentally infected with M. dispar and in mice immunized with 
CPS showed that the immune response was typical of the response produced to 
polysaccharide antigens which have been characterized as thymus-independent 
antigens [13). In experimentally infected calves, serum lgM response peaking at 
14 days post-infection and a local humoral response (as measured in 
tracheobronchial lavage fluid) consisting of lgM and lgA was seen 12 days post-
infection. An lgA response would normally not be expected if the antigen was 
exclusively polysaccharide because of limited T-cell involvement. However, in the 
case of infection, the host sees the polysaccharide antigen (CPS) in conjunction 
with M. dispar proteins and so it is possible that a small amount of T-cell 
involvement is present which enables antibody class switching from lgM to lgA. 
The same reason could also explain the in vitro lymphocyte proliferation seen in 
response to 0.3 µg of CPS (12 µg I ml). Polysaccharide-specific lgA antibodies 
have been shown to be produced in certain strains of mice such as C57BL/6, 
which were immunized with purified dextran [5]. The lgM and lgA antibody 
responses seen in the calves peaked at about 2 weeks post infection and then 
declined progressively such that by 5 weeks post-infection antibody levels were 
similar to pre-infection levels. Since M. dispar was isolated from the lung tissues 
and lavage fluid 5 weeks post-infection, the immune response produced appeared 
to be incapable of completely clearing the organism from the host. To perform 
these studies , calves had to be raised under conditions that minimized nonspecific 
antibody responses to CPS. Therefore , the calves were raised on starch-free diet 
in isolation rooms in order to avoid antibodies that might be formed due to 
exposure to other polysaccharide antigens such as starches that are present in the 
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hay and to CPS of other micro-organisms. They were fed limited colostrum to limit 
passive transfer of maternal lgG antibodies. 
Mice immunized with CPS and pGalU produced exclusively lgM responses. 
However, no secondary response was seen in mice immunized with CPS in 
contrast to mice immunized with pGalU. The absence of the secondary response 
could be explained by : a) B-cells were tolerized with the second dose of CPS but 
not with pGalU, b) CPS was immunosuppressive but pGalU was not, at least not 
to the same extent. The difference in to le rogenicity between CPS and pGalU may 
be due to the differences in the molecular weights, epitope density or extent of 
persistence of the two polysaccharides. These factors have been found to 
considerably affect the tolerogenicity and immunogenicity of many polysaccharide 
and other thymus-independent antigens [9, 3, 4] . For example , the tolerogenicity of 
~2-6-linked polyfructose disappeared as its molecular weight was reduced from 
6000 to 3000 [9] . The molecular weight of pGalU is 4,000 daltons in average 
whereas that of CPS is at least greater than 14,000 daltons [2]. The fact that the 
same dose of CPS (0.5 µg) was immunogenic after the first injection but 
tolerogenic after the second injection can be explained by the fact that the primed 
B cells are tolerized more easily than the potentially responsive mature B cells in 
unprimed mice [1 O]. 
The antibodies in the sera of mice immunized with CPS cross-reacted with 
pGalU but antibodies cross-reactive with CPS were not found in the sera of 
pGalU-immunized mice. This might indicate that among the epitopes presented by 
the CPS, there may be a few which are very similar to some of the epitopes of 
pGalU. As expected of thymus-independent antigens, no CPS-specific or pGalU-
specific lymphocyte proliferation was seen in mice. 
In order for the animal to be able to protect itself against infection and tissue 
damage, the immune responses to the capsular antigen would have to be thymus-
dependent so that the host's immune system would be capable of elicit ing an 
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anamnestic response, produce antibodies with much higher affinity to CPS and 
also produce lgG antibodies which can be transferred to the newborn through 
placenta and colost rum. Structural modifications via chemical methods and 
coupling of the polysaccharide with suitable protein carriers [16] are some of the 
approaches that could be utilized to construct thymus-dependent forms of the 
CPS. 
In conclusion , the CPS of M. disparwas shown to be a T-independent antigen 
that elicited humoral responses cross-reactive to pGalU, a structurally similar 
polysaccharide. The CPS of M. dispar differed from pGalU as evidenced by one-
way cross-reactivity of antibody responses and divergent memory responses. 
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Figure 1: Serum lgM response in M. dispar infected calves to CPS and pGalU. 
Bars represent mean absorbance at 550 nm (mean ± SEM ; n = 3 calves). 
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0, day 12 and day 35 post-infection with M. dispar, in response to CPS and pGalU. 
Bars represent the mean absorbance at 550 nm (mean ± SEM ; n = 3 calves). 
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Figure 3: Serum lgM response in mice injected with CPS and pGalU tested 
against CPS. Bars represent the mean difference in absorbance at 550 nm 
calculated as post immunization serum absorbance - pre immunization serum 
absorbance (mean ± SEM; n = 4 mice in each group) ; p's< 0.001. 
5 2 
E 
0.2 
c 
0 0 CPS LO 
LO • pGalU Ci; 
Q) 
0 
c 
co 
.0 
0.1 ...... 0 
(/) 
.0 
co 
c 
Q) 
(/) 
co 
Q) ...... 
g 
0.0 
0 3 5 9 1 2 1 4 1 7 19 21 
t Days t 
1st dose 2nd dose 
Figure 4: Serum lgM response in mice injected with CPS and pGalU tested 
against pGalU. Bars represent the mean difference in absorbance at 550 nm 
calculated as post immunization serum absorbance - pre immunization serum 
absorbance (mean ± SEM; n = 4 mice in each group); p's < 0.001 . 
>< 
<1> 
-0 
c 
c 
0 
§ 
::J 
E 
U5 
2 
0 
- 7 
53 
0 7 14 2 1 28 35 
Days 
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is represented by the dotted line. 
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STRUCTURAL INVESTIGATION OF THE CAPSULAR 
POL YSACCHARIDE OF MYCOPLASMA DISPAR 
A paper to be submitted to Carbohydrate Research 
Praveen Bansal and R.F. Rosenbusch 
ABSTRACT 
The structure of the capsular polysaccharide (CPS) of Mycoplasma dispar 
was investigated by 13C-n.m.r. spectroscopy and acidic hydrolysis. A chemical 
shift at 175 ppm was seen in the 13C-n.m.r. spectra of CPS which indicated the 
presence of the carboxyl groups. Acidic hydrolysis of CPS showed the presence of 
galacturonic acid and galactose residues. In addition, the hydrolyzate of CPS 
showed two more spots which could not be identified. The uronic acid content in 
the CPS was found to be 22 %. Based on the mass spectra of the methylated 
CPS, the structure of CPS was proposed to be : 
-->3) - a - Galp - (1-->2) - a - GalUA - (1 -->3) - a - Galp - (1--> 
3 
~Galp- 1 
INTRODUCTION 
Mycoplasma dispar is a capsulated mycoplasma that produces chronic 
infection of the lower respiratory tract in calves resulting in local 
immunosuppression and specific lesion production. The capsular polysaccharide 
(CPS) is produced by the mycoplasma during natural infections3 and in vitro, 
under conditions of co-culture with bovine lung fibroblasts2. This CPS has been 
shown to be involved in the suppression of several alveolar macrophage functions 
such as tumor necrosis factor and interleukin-1 production1 . Thus, the CPS 
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appears to be a major virulence factor. 
Although the structures of CPS from many bacteria such as Klebsiella , 
Escherichia coli and Haemophilus influenzae have been elucidated, very few 
studies have been focused on structu res of the mycoplasma capsules. Here we 
report structural studies performed on the CPS of M. dispar. 
EXPERIMENTAL 
Isolation of CPS --- The CPS of Mycoplasma dispar was produced and 
purified according to the method of Almeida et a11 , with minor modifications. 
Briefly, M. dispar cel ls were co-cultured with bovine lung fibroblast monolayers for 
23 hours. After separating the mycoplasmas from the bovine cells and washing 
them in PBS three times at 4°C, capsule was extracted by incubating the 
mycoplasmas in phosphate-buffered saline at 37°C for 1 hour. The supernatant 
obtained after centrifugation was lyophilized. This preparation was then purified by 
capturing the CPS on agarose bound Ricinus communis agglutinin I or RCA120, 
(Vector, Burlingame, CA) , washing the beads and eluting with 0.1 M galactose. 
The eluate was then passed through a Biogel P4 (Bio-Rad, Melville , NY) size 
exclusion column using distilled water as the running buffer. Each collected 
fraction was analyzed for the presence of CPS by thin-layer chromatography. A 
sample of 1 µI of each fraction was spotted on si lica gel plate (E. Merck, 
Darmstadt, Germany) and was run in a solvent system of 1-butanol, acetic acid 
and water in the ratio of 2:1 :1. The carbohydrate spots were visualized by dipping 
the plate in a reagent made up of 0.5 g thymol , 0.5 g cx-naphthol, 5 ml sulfuric acid 
and 95 ml ethanol and heating the plate for 1 O minutes at 120°C. The fractions that 
had CPS were pooled and lyophilized. The protein and nucleic acid 
contamination in the purified CPS preparation was checked by measuring A280 
and A260· 
Polygalacturonic acid , sodium salt was obtained from Sigma Chemical Co. , 
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St. Louis, MO. 
Acid hydrolysis --- Acidic hydrolysis of CPS (1 O mg I ml) was performed 
with 4 M trifluoroacetic acid at 121 ° C for 1 hour. Hydrolyzate was analyzed by thin 
layer chromatography using 1-butanol, acetic acid and water in the ratio of 2:1 :1 
as the solvent. 
Uronic acid content --- Uronic acids were estimated by the carbazole 
method as described by Knutson et al4 with minor modifications. Sulfuric acid -
borate reagent was prepared by dissolving 0.95 g of sodium tetraborate in 2.0 ml 
of hot water and then adding 98 ml of ice-cold concentrated sulfuric acid to it. The 
reagent (1 .5 ml) was pipetted in each tube and kept in an ice-bath. One hundred 
and seventy five microliters of the sugar solution (50 - 800 µg I ml) was added to 
sulfuric acid - borate reagent and the tubes were again placed on ice. One 
hundred microliters of the carbazole solution (0.125 % in absolute ethanol) was 
then added. The contents of each tube were mixed well and the tubes were 
heated at 55° C for 30 minutes. The tubes were then allowed to sit at room 
temperature for 2 hours before measuring the absorbance at 530 nm. 
N.m.r. spectroscopy --- The proton decoupled 13C-n.m.r. spectra were 
recorded with a VXR-300 spectrophotometer, using 0 20 as solvent. The spectra 
were recorded at 4° C and chemical shifts were expressed in reference to carbon 
disulfide. 
Methylation analysis --- Methylation of CPS was performed according to 
the conditions of Stellner et al5 with minor modifications. Hakomori reagent was 
prepared by stirring a 50 % dispersion of sodium hydride in mineral oil (3.0 g) into 
dry DMSO (40 ml) by a magnetic stirring bar coupled to an air driven motor in an 
ultrasonic bath . Dry nitrogen was blown over the surface of the mixture and the 
reaction was allowed to proceed at 50° C for about 4 hours by which time a clear 
green solution was obtained. The reagent was stored under 1 cm thick mineral oil 
in plastic cryovials in the freezer. 
The carbohydrate , CPS (10 mg) was dissolved in water (2 ml) and 1 O µg of 
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sodium borohydride was added. The reaction mixture was kept overnight. Excess 
sodium borohydride was decomposed with prewashed Dowex 50 hydrogen form 
(Sigma, St. Louis, MO). The sample was filtered through a membrane filter and the 
solution evaporated to dryness. The dried sample was dissolved in 1.0 ml of dry 
DMSO in a septum-stopped tube. Dry nitrogen was flushed through the tube and 
0.4 ml of Hakomori reagent was added. The solution was agitated in the 
ultrasonic bath for 2 hours. Methyl iodide (0 .4 ml) was then added dropwise and 
the cleared mixture was partitioned between chloroform - water (3 ml: 6 ml) three 
times. The chloroform layer was dried with 4 A molecular sieves (Fisher, Itasca, IL) 
and then evaporated to dryness. Stellner's reagent (1 ml) was added and the 
reaction mixture kept at go° C for 4 hours. Water (1 ml} was then added and the 
reaction was allowed to occur for 4 hours at go° C. The resulting sample was 
passed through a column of Dowex AG2 - xg, acetate form . The column was 
washed sequentially with 1.5 bed volumes each of water and methanol. The 
resulting solution was lyophilized. The lyophi lized sample was dissolved in 1 ml of 
water, to which 10 mg of sodium borohydride was added. After about 2 hours, 
excess sodium borohydride was decomposed with Dowex 50 hydrogen form. After 
filtration through a membrane filter, the solution was evaporated to dryness. The 
res idue was treated with acetic anhydride-pyridine; 1 :1 (4 ml) for 30 minutes at 60° 
C. The mixture was then partitioned between chloroform - water (3 ml : 6 ml) three 
times. The chloroform layer was dried with 4 A molecular sieves and the sample 
was concentrated by blowing dry nitrogen over it. The acetylated sample was 
analyzed by g.c-m.s using a DB-5 column. 
RESULTS 
Sugar analysis --- The uronic acid content in the CPS of M. disparwas 
found to be 22 % by carbazole analysis. Acidic hydrolysis of CPS for 1 hour with 4 
M TFA showed 4 spots on the TLC (Table 1 ). Two out of the 4 spots could be 
identified as 0-galacturonic acid and 0-galactose and the other two could not be 
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identified. 
N.m.r. spectra --- 13C n.m.r. spectra of CPS showed 4 clear peaks (Fig. 1 ). 
One was at 17 4.90 for the C=O of the carboxyl group and 3 peaks at 50.5, 56.6 
and 59.2 ppm for C-2, C-3 and C-4 of galactose respectively. In addition , one very 
small peak at 105.1 ppm corresponding to the anomeric carbon atom and another 
small peak at 61 .0 ppm for C-5 was seen. 
Methylation analysis --- The mass spectra of the methylated CPS is 
shown in figure 2. The peaks obtained could be explained when the CPS was 
proposed to be a tetrasaccharide repeat consisting of three neutral sugar residues 
(all galactose residues) and one charged galacturonic acid residue. The 
galacturonic acid residue and two galactose residues form the backbone and one 
galactose residue forms the side chain (Fig. 3) 
The various possible fragments that would be obtained from the proposed 
structure when subjected to the methylation process which could account for the 
peaks seen in the mass spectra of the methylated CPS are shown in figure 4. 
DISCUSSION 
The immunogenicity and the immunological specificity of polysaccharides is 
dictated by their structures. Hence, in order to understand the immunology of 
polysaccharides and to develop effective prophylactic vaccines against 
encapsulated microorganisms, it is imperative that the structure of the 
polysaccharide capsule be elucidated. Structural investigation of the CPS of M. 
dispar revealed that the CPS consisted at least of galacturonic acid and galactose 
residues. Since the uronic acid content was found to be 22 % acidic sugar, it may 
indicate that out of every 4 residues in the CPS, one of them is galacturonic acid. 
We have demonstrated that there is considerable cross-reactivity among anti-CPS 
and anti-polygalacturonic acid antibodies5. This may indicate that galacturonic 
acid may be the immunodominant sugar. 
Hydrolysis of the CPS with TFA showed 4 spots , out of which 2 could not be 
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identified. Both these spots had higher Rt values than galactose or galacturonic 
acid . These could be other hexoses or they could be 4-C or 5-C degradation 
products of galacturonic acid. 
Direct chemical analyses of few mycoplasma capsules has been reported. 
The CPS of M. mycoides subsp. mycoides is a galactan which is made up of a 
repeating unit of ~-D-galactofuranosyl-(1 -->6) -D-galactopyranose? . The 
predominant structural unit of the glucan from the Mycoplasma sp. bovine arthritis 
strain is ~-D-glucopyranosyl-(1-->2)-D-glucopyranoses . The composition of the 
polysaccharide obtained from F-38 strain of mycoplasma (etiologic agent of 
contagious caprine pleuropneumonia) was determined to be a mixture of glucose, 
galactose, mannose, fucose, glucosamine and galactosamine in approximately 
equal quantities9. In all these cases, the purification of the capsular material was 
accomplished by using hot phenol extraction procedures followed by ethanol 
precipitation or ion-exchange chromatography. It has been shown that hot phenol 
extraction causes the removal of lipoglycans present in the mycoplasma 
membrane1 0. The results could , therefore , have been affected by the presence of 
such impurities. 
D-Galacturonic acid residues have been shown to be present in a number 
of bacterial capsules such as those of Klebsiella serotype K 4911 and 
Streptococcus pneumoniae. This report shows that the CPS of M. dispar 
possesses such galacturonic acid residues. 
TABLE I: 
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Rt values of the components obtained by acid hydrolysis of 
CPS and pGalU . 
Compound 
CPS 
Component 
Galacturonic acid 
Ga lactose 
Unidentified 
Unidentified 
0.341 
0.488 
0.682 
0.804 
64 
:>:: LZ :z: a.. a..a.. a.. 
CL a..o.. CL 
.n O<O "' 0 00 m C\JlO "' .... 01<0 0 ,.... lfllll in 
MT; .... 
( (( ) I 
"" ' l l I r ., 
I I II I " " I ' I I I I " " I " I I I ' I I " " ' I I ' ' " " I " I ' I " I ' " I I ' " I " I II I ' I I " I " I I " I II II II I " ' " " I ' I ' I II II I II I II ' II II I ' I' II I II II ' 111 ' " I " I I ' " II II II I ' 
180 170 150 150 140 130 120 110 100 90 BO 70 50 50 .. o 
PPM 
Figure 1 13 C NMR of CPS 
I 00 - RO 
50 --
94 
0 
I, .'.121 11 .. IT' 291 1---J....ai-..~fit"~u..vJ.,.r~, ,.~j , 1 ·t T 1f-rl· ~ . , ~ 
I 00 150 200 250 300 
Figure 2: Mass spectra of methylated CPS 
) 'JI 
368 
J26 ~ 410 I I 351 ' ' rrr -,..-, T~-,.-, 
350 '100 
4.52 
1 I r111- 1 
'150 500 
m 
(J1 
66 
OH 
HOOC 
0 -
HO 
n 
Figure 3: Proposed structure of CPS 
A) 
B) 
67 
277b 
117 
233 
189 
161 
233 
117 
305 
45 
mle = 350 
mle 161 - mle 32 (CH30H) --> mle 129 - mle 42 (C2H20) --> mle 87 
mle 232 - mle 60 (CH3COOH) --> mle 173 
mle 277 - m/e 32 --> mle 245 - mle 42 --> mle 203 
H-C-OAc 
I 
kO-C-H 
I 
MeO-C-H 
I 
H-C-OAc 
I 
mle = 392 
73 
319 
145 
247 
217 
175 
261 
131 
mle 175 - m/e 32 --> mle 143 - mle 42 --> mle 101 
mle 247 - mle 60 --> m/e 187 
mle 319 - mle 60 --> mle 259 
333 
59 
Figure 4: Fragmentation of methylated products obtained from residues A and B as 
indicated in Fig. 3 
a The figures are the m/e values of the upper fragment 
b The figu res are the m/e values of the remaining fragment 
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Figure 5: Fragmentation of methylated products obtained from residues C and D 
as indicated in Fig . 3 
aThe figures given are the m/e values of the upper fragment 
bThe figures given are the m/e values of the remaining fragment 
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GENERAL SUMMARY 
Three research goals were outlined in the Introduction section of this thesis. 
The first, to characterize the immune responses towards pGalU and to the purified 
capsule of M. dispar in mice and the second, to characterize the immune 
responses to CPS and pGalU in M. dispar infected cattle have been achieved. The 
first goal was aimed at understanding the antigenic nature of the purified CPS. 
Generally, polysaccharides have been classified as thymus-independent type 2 
antigens. The results obtained from the studies done in mice strongly indicate that 
the purified CPS acts as a typical thymus-independent antigen. It was however not 
possible to state the particular type to which it belongs i.e. whether type 1 or 2 
thymus-independent antigen because that would require that the studies be done 
in neonatal and xid mice. The studies done in M. dispar infected cattle support the 
thymus-independent antigenic nature of CPS. These studies were necessary in 
order to make sure that the association of CPS with M. dispar did not endow 
unique properties to the CPS and also that the process of extraction and 
purification of CPS did not destroy or alter the antigenicity or immunogenicity of 
the CPS. 
These two goals were also aimed at studying the cross-reactivity among the 
antibodies directed towards CPS and pGalU. Studies in mice and in calves 
indicate considerable cross-reactivity which means that there is potential for use of 
inexpensive, commercially available pGalU instead of CPS in vaccines based on 
the polysaccharide antigen . 
The third research goal was to chemically characterize the structure of CPS. 
This goal has been partly achieved. One of the major hurdles in accomplishing 
this goal was the lack of availabi lity of large amounts of purified CPS. However, 
the data obtained does indicate similarity between CPS and pGalU acid. The 
presence of 22 % acidic sugar may indicate that among every 4 residues there is 
one galacturonic acid residue. The considerable cross-reactivity seen among anti-
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CPS and anti-pGalU antibodies may also indicate that the galacturonic acid 
residue is the immunodominant sugar. 
Overall, this work provided good evidence for the thymus-independent 
nature of the CPS of M. disparwhich may explain the ability of M. disparto 
establish chronic colonization of the lower respiratory tract in calves. Structural 
studies performed revealed that the CPS contained galacturonic acid and 
galactose residues. The presence of the galacturonic acid residues formed the 
basis of the cross-reactivity seen among the CPS-specific and pGalU-specific 
antibodies. 
Since , the thymus-independent responses seen in M. dispar infected calves 
appeared to be incapable of clearing the organism from the host it is evident that 
forms of CPS that induce thymus-dependent responses will have to be 
constructed. Since there is structural similarity between polygalacturonic acid and 
CPS, it may be possible to use chemically modified forms of pGalU or pGalU-
protein conjugates for inducing immunity in calves. 
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APPENDIX. STUDY OF IMMUNE RESPONSES IN CATTLE 
IMMUNIZED WITH POL YGALACTURONIC ACID 
INTRODUCTION 
This appendix summarizes an attempt to study the antibody responses 
towards the capsular polysaccharide (CPS) of M. dispar and polygalacturonic 
acid (pGalU) in cattle immunized with pGalU. 
There is preliminary evidence that the capsule of M. dispar is similar in 
chemical composition to polygalacturonic acid which is found in citrus rinds and 
other plant tissues.To determine whether polygalacturonic acid could replace 
CPS as the antigen in vaccines it was necessary to characterize the imune 
response to polygalacturonic acid in catt le and examine whether the antibodies 
produced towards polygalacturonic acid would cross-react with CPS. 
MATERIALS AND METHODS 
Cattle 
Thirteen cross-bred beef type steers, 17 to 15 months old, were injected 
subcutaneously with 2.5µg of polygalcturonic acid in 2 ml of saline to which 1 ml of 
Alum Inject (Pierce, Rockford, IL) was added and test bled for serum samples 
according to the following schedule: 
.Q.mt. SamplinQ 
dO Test bled and 1st vaccination 
d 14 Test bled 
d30 Test bled and 2nd vaccination 
d35 Test bled 
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Serums were collected and stored at -20C until tested for the presence of lgG and 
lgM antibodies to polygalcturonic acid and CPS using ELISA. 
ELISA 
The assay was performed as has been described previously in paper 1. 
The controls used in the test were : 
1. Substrate control : RCA120 +CPS+ substrate 
2. Conjugate control : RCA120 + CPS + horseradish peroxidase conjugated goat 
anti rabbit lgG + substrate 
3. Anti-class control : RCA120 +CPS+ rabbit anti bovine lgG or lgM +horseradish 
peroxidase conjugated goat anti rabbit lgG + substrate 
Statistical analysis 
Analysis of variance (Table 5.0) was done to see whether there were any 
significant differences in the antibody levels on different days. 
RESULTS 
Both anti-CPS (Table 1 and 2) and anti-pGalU antibodies (Table 3 and 4) 
could be detected in the sera of the steers vaccinated with pGalU. The anti-pGalU 
lgM antibody values were higher than anti-pGalU lgG, anti-CPS lgM and anti-CPS 
lgG values. Table 5 shows the means and the standard errors of means of the anti-
CPS and anti-pGalU antibody values obtained from the sera of the thirteen steers. 
After immunization with pGalU, no lgG response was seen with either CPS 
or pGalU. However, significant changes in the anti-CPs anti-pGalU levels were 
seen after immunization. The anti-CPS level decreased significantly at 30 days 
post-immunization. After the second dose of pGalU, the anti-CPS antibody level 
increased and reached the pre-immunization level. The anti-pGalU lgM level 
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decreased significantly at day 14 post-immunization , then increased such that by 
day 30 the antibody level was same as the pre-immunization level and then 
decreased again after the second immunization such that the lgM level was similar 
to that on day 14 post-immunization. 
DISCUSSION 
Carbohydrates are considered as thymus-independent antigens which means that 
they induce primarily a humeral response and the antibody isotype is 
predominantly lgM. However, no increase in the anti-CPs or anti-pGalU lgM level 
over the pre-immunization was seen. The anti-pGalU level declined 14 days post-
immunization, climbed back by day 30 and then declined again after the second 
dose of pGalU. This may indicate a phenomenon of antibody-mediated 
suppression. The first dose of antigen (pGalU) resulted in the clearance of some 
already present anti -polysaccharide antibodies. This decrease in the antibody 
level enabled the antigen to activate specific B cells resulting in the production of 
specifi c antibodies. After the second injection, the antigen again cleared the 
preexisting antibodies resulting in a decrease of anti-pGalU antibodies. 
From the above results it is evident that the steers had high levels of 
preexisting levels of antibodies to pGalU and also to the CPS of M. dispar 
(although these steers came from a M. disparfree herd). This reactivity to the CPS 
and to pGalU may have stemmed from two possible sources: antibodies may have 
been produced in response to the various carbohydrates in the feed or due to the 
exposure to the CPS of other bacteria. It becomes clear that t study the immune 
responses to pGalU or to the M. dispar CPS, calves will have to be raised in 
isolation so that they do not get exposed to other encapsulated bacteria and 
should preferably be fed a non - starch diet. 
Table 1: 
Steer # 
Results of antoglobulin-ELISA for detecting anti-CPS lgG antibodies in sera of the 
thirteen steers before and following vaccination with pGalU 
Day 432 434 439 440 441 442 443 444 445 446 447 450 452 
0 .206a .203 .205 .204 .195 .241 .237 .225 .224 .210 .209 .207 .205 
14 .202 .193 .197 .201 .199 .244 .237 .228 .226 .220 .211 .207 .240 
30 .201 .205 .209 .202 .197 .219 .233 .230 .223 .225 .203 .204 .238 
35 .184 .200 .208 .196 .204 .228 .232 .229 .226 .235 .208 .208 .233 
aThe figures given are optical density at 550 nm. 
tO 
CXl 
Table 2: Results of antiglobulin-ELISA for detecting anti-CPS lgM antibodies in sera of the 
thirteen steers before and following vaccination with pGalU 
Steer# 
Day 432 434 439 440 441 442 443 444 445 446 447 450 452 
0 .246a .244 .216 .251 .196 .258 .269 .234 .180 .227 .249 .252 .278 
14 .214 .251 .21 9 .228 .197 .269 .238 .186 .209 .235 .246 .260 .262 
30 .224 .265 .230 .230 .172 .227 .251 .166 .1 80 .203 .237 .265 .241 
35 .227 .248 .255 .245 .216 .229 .239 .1 88 .180 .230 .237 .265 .241 
aThe figures given are optical density at 550 nm 
CD 
CD 
Table 3: 
Steer# 
Results of antiglobulin-ELISA for detecting anti-pGalU lgG antibodies in sera of the 
thirteen steers before and following vaccination with pGalU 
Day 432 434 439 440 441 442 443 444 445 446 447 450 452 
0 .179a .187 .196 .197 .207 .217 .211 .190 .233 .261 .227 .194 .184 
14 .198 .199 .198 .205 .192 .208 .205 .201 .222 .221 .229 .225 .190 
30 .198 .199 .1 86 .195 .214 .211 .208 .169 .223 .227 .189 .217 .174 
35 .191 .208 .201 .1 89 .204 .21 5 .207 .194 .218 .226 .219 .215 .1 88 
aThe figures given are optical density at 550 nm 
0 
0 
Table 4: 
Steer# 
Results of antiglobulin-ELISA for detecting anti-pGalU lgM antibodies in sera of the 
thirteen steers before and following vaccination with pGalU 
Day 432 434 439 440 441 442 443 444 445 446 447 450 452 
0 .301 a .302 .296 .308 .317 .313 .31 5 .297 .260 .291 .294 .304 .289 
14 .287 .306 .294 .301 .285 .295 .302 .244 .202 .286 .276 .285 .292 
30 .304 .293 .306 .307 .305 .305 .315 .267 .253 .299 .273 .290 .290 
35 .278 .293 .307 .294 .279 .301 .287 .266 .187 .293 .291 .278 .288 
aThe figures given are optical density at 550 nm 
0 
Table 5: 
Antibodies 
Anti-CPS lgG 
Anti -CPS lgM 
Anti-pGalU lgG 
Anti-pGalU lgM 
Results of antiglobulin-ELISA for detecting anti-CPS lgG, lgM and anti-pGalU lgG , 
lgM in sera of thirteen steers 
Days 
0 
a.213 ± .0036 
.238 ± .0072 
.206 ± .0061 
.299 ± .0061 
14 
.216 ± .0047 
.232 ± .0069 
.207 ± .0033 
.281 ± .0074 
30 35 
.215 ± .0036 .215 ± .0044 
.220 ± .0083 .231 ± .0063 
.201 ± .0047 .206 ± .0033 
.293 ± .0049 .280 ± .0080 
aThe figures given are the means of the values± the standard error mean of the optical 
density at 550 nm of the sera of the thirteen steers when tested by antiglobulin-ELISA 
-' 
0 
N 
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Table 6.1: Analysis of variance table of anti-CPS lgG antibodies 
Source 
Cow 
Day 
aDF 
12 
3 
aDF =degrees of freedom 
bSS =sum of squares 
Anova bSS 
0.00969092 
0.00004492 
F value 
13.84 
0.26 
Pr> F 
0.0001 
0.8561 
Table 6.2 : Analysis of variance table of anti -CPS lgM antibodies 
Source 
Cow 
Day 
aDF 
12 
3 
aDF = degrees of freedom 
bSS = sum of squares 
Anova bSS 
0.02830658 
0.00209883 
F value 
10.59 
3.14 
Pr> F 
0.0001 
0.0370 
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Table 6.3: Analysis of variance table of anti-pGalU lgM antibodies 
Source 
Cow 
Day 
aOF 
12 
3 
aOF = degrees of freedom 
bSS = sum of squares 
Anova bSS 
0.02169892 
0.00328360 
F value 
12.10 
7.33 
Pr > F 
0.0001 
0.0006 
Table 6.4 : Analysis of variance table of anti -pGalU lgG antibodies 
Source 
Cow 
Day 
a OF 
12 
3 
aOF =degrees of freedom 
bSS =sum of squares 
Anova bSS 
0.01018073 
0.00032560 
F value 
7.41 
0.95 
Pr > F 
0 .0001 
0.4278 
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Table 7: Duncan multiple range test for anti-CPS lgM antibodies 
Duncan Grouping 
A 
A 
A 
B 
Mean 
0.238462 
0.231846 
0.230692 
0 .220692 
Day 
0 
14 
35 
30 
